Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.Med.Sc., Harvard Medical School 2002
  • Research Fellowship in Nephrology, Massachusetts General Hospital 2000 - 2001
  • Clinical Fellowship in Nephrology, Brigham and Women's Hospital 1999 - 2000
  • Internal Medicine Residency, Massachusetts General Hospital 1996 - 1999
  • M.D., State University of New York, Brooklyn 1996
• 

  Previous Appointments & Affiliations

  • Instructor, Temporary in the Department of Medicine, Medicine, Nephrology, Medicine 2016 - 2017
• Research
• 

  Selected Grants

  • Tissue-Specific Regulation and Effects of CYP24A1 awarded by National Institutes of Health 2023 - 2027
  • Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23) awarded by National Institutes of Health 2021 - 2026
  • JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease awarded by National Institutes of Health 2021 - 2026
  • Diet and Hypertension Management in Chronic Kidney Disease awarded by National Institutes of Health 2019 - 2024
  • Endocrinology and Metabolism Training Program (T32) awarded by National Institutes of Health 2019 - 2024
  • Metabolic regulation of pancreatitis awarded by National Institutes of Health 2020 - 2024
  • A phase 2b/3 Randomized Clinical Trial of Clazakizumab in Patients with End Stage Kidney Disease Undergoing Dialysis awarded by CSL Behring LLC 2022 - 2023
  • "HiLo": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis awarded by National Institutes of Health 2018 - 2023
  • Duke Training Grant in Nephrology awarded by National Institutes of Health 1995 - 2023
  • Postdoctoral Training in Genomic Medicine Research awarded by National Institutes of Health 2017 - 2023
  • Duke CTSA (TL1) Year 5 awarded by National Institutes of Health 2018 - 2023
  • The Role of Klotho and Serotonin in Cardiovascular Outcomes and Mortality in CKD awarded by University of Pennsylvania 2021 - 2022
  • Targeting anti-ferroptotic pathways to prevent the AKI-to-CKD transition awarded by  American Heart Association 2020 - 2021
  • Harnessing Antioxidative Stress Pathways in Renal Epithelial Progenitors to Prevent AKI-to-CKD Transition awarded by ASN Foundation for Kidney Research 2019 - 2020
  • Pencast Videos to Boost Learning and Interest in Nephrology Among Internal Medicine Residents awarded by American Society of Nephrology 2017 - 2020
  • Molecular Mechanisms of Cardiac Injury Induced by FGF23 in the Settings of High Phosphate Diet and CKD awarded by Northwestern University 2016 - 2020
  • Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovasular and Kidney Diseases (Center) awarded by Northwestern University 2016 - 2020
  • FGF23 and Cardiovascular Disease in CKD (CRIC) awarded by National Institutes of Health 2013 - 2019
  • Role of FGF23 in Mineral Metabolism Across the Spectrum of Chronic Kidney Disease awarded by National Institutes of Health 2013 - 2019
  • Pilot Studies Targeting Mineral Metabolism in CKD awarded by Northwestern University 2013 - 2019
  • Impact of phosphate and FGF23 reduction on intermediate end points in CKD awarded by Northwestern University 2017 - 2019
  • Vitamin D Catabolism in Chronic Kidney Disease awarded by University of Washington 2016 - 2019
  • FGF-23 and Clinical outcomes in ADPKD awarded by University of Colorado - Denver 2016 - 2018
  • Mentored Patient-Oriented Research in Mineral Metabolism awarded by National Institutes of Health 2012 - 2017
• 

  External Relationships

  • Akebia
  • Amgen, Inc.
  • Bayer
  • Enyo
  • Jnana
  • Medscape ( WebMD HLTH Corp.)
  • Pharmacosmos
  • Reata Pharmaceuticals, Inc.
  • Unicycive
  • Walden Biosciences
• Publications & Artistic Works
• 

  Selected Publications

  • Books

    • Musgrove, John, and Myles Wolf. Regulation and Effects of FGF23 in Chronic Kidney Disease. Vol. 82, 2020. https://doi.org/10.1146/annurev-physiol-021119-034650.
       Full Text  Link to Item
    • Pool, Lindsay R., and Myles Wolf. FGF23 and Nutritional Metabolism. Vol. 37, 2017. https://doi.org/10.1146/annurev-nutr-071816-064620.
       Full Text  Link to Item
    • Portale, A. A., M. Wolf, H. Jüppner, S. Messinger, J. Kumar, K. Wesseling-Perry, G. J. Schwartz, S. L. Furth, B. A. Warady, and I. B. Salusky. Disordered FGF23 and mineral metabolism in children with CKD. Vol. 114, 2016. https://doi.org/10.1159/000441813.
       Full Text

  • Academic Articles

    • Garg, Gaurang, Yacob G. Tedla, Anika S. Ghosh, Dinushika Mohottige, Marynia Kolak, Myles Wolf, and Abel Kho. “Supermarket Proximity and Risk of Hypertension, Diabetes, and CKD: A Retrospective Cohort Study.” Am J Kidney Dis 81, no. 2 (February 2023): 168–78. https://doi.org/10.1053/j.ajkd.2022.07.008.
       Full Text  Link to Item
    • Dream, Sophie, Lindsay E. Kuo, Jennifer H. Kuo, Stuart M. Sprague, Fiemu E. Nwariaku, Myles Wolf, John A. Olson, Sharon M. Moe, Brenessa Lindeman, and Herbert Chen. “The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Secondary and Tertiary Renal Hyperparathyroidism.” Ann Surg 276, no. 3 (September 1, 2022): e141–76. https://doi.org/10.1097/SLA.0000000000005522.
       Full Text  Link to Item
    • Schaefer, Benedikt, Heinz Zoller, and Myles Wolf. “Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.” J Clin Endocrinol Metab 107, no. 4 (March 24, 2022): 1009–19. https://doi.org/10.1210/clinem/dgab852.
       Full Text  Link to Item
    • Akhabue, Ehimare, Mandy Wong, Rupal Mehta, Tamara Isakova, Myles Wolf, Clyde Yancy, Orlando M. Gutierrez, and Mercedes Carnethon. “Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.” Am Heart J 245 (March 2022): 10–18. https://doi.org/10.1016/j.ahj.2021.11.009.
       Full Text  Link to Item
    • Bundy, Joshua D., Mahboob Rahman, Kunihiro Matsushita, Byron C. Jaeger, Jordana B. Cohen, Jing Chen, Rajat Deo, et al. “Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.” J Am Soc Nephrol 33, no. 3 (March 2022): 601–11. https://doi.org/10.1681/ASN.2021060747.
       Full Text  Link to Item
    • Cohen, Jordana B., Wei Yang, Liang Li, Xiaoming Zhang, Zihe Zheng, Paula Orlandi, Nisha Bansal, et al. “Time-Updated Changes in Estimated GFR and Proteinuria and Major Adverse Cardiac Events: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.” American Journal of Kidney Diseases : The Official Journal of the National Kidney Foundation 79, no. 1 (January 2022): 36-44.e1. https://doi.org/10.1053/j.ajkd.2021.03.021.
       Full Text
    • Fujii, Naohiko, Takayuki Hamano, Jesse Y. Hsu, Enyu Imai, Tadao Akizawa, Kosaku Nitta, Tsuyoshi Watanabe, et al. “A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan.” Am J Nephrol 53, no. 2–3 (2022): 226–39. https://doi.org/10.1159/000521386.
       Full Text  Link to Item
    • Schaefer, Benedikt, Moritz Tobiasch, Sonja Wagner, Bernhard Glodny, Herbert Tilg, Myles Wolf, and Heinz Zoller. “Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.” Bone 154 (January 2022): 116202. https://doi.org/10.1016/j.bone.2021.116202.
       Full Text  Link to Item
    • Zoller, H., M. Wolf, I. Blumenstein, C. Primas, S. Lindgren, L. L. Thomsen, W. Reinisch, and T. Iqbal. “Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): A randomised clinical trial.” Gut, January 1, 2022. https://doi.org/10.1136/gutjnl-2022-327897.
       Full Text
    • Kula, Alexander J., Ronit Katz, Leila R. Zelnick, Elsayed Soliman, Alan Go, Michael Shlipak, Rajat Deo, et al. “Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease.” Nephrol Dial Transplant 36, no. 12 (December 2, 2021): 2282–89. https://doi.org/10.1093/ndt/gfaa296.
       Full Text  Link to Item
    • Mehta, Rupal C., Monique E. Cho, Xuan Cai, Jungwha Lee, Jing Chen, Jiang He, John Flack, et al. “Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.” Kidney Int 100, no. 6 (December 2021): 1292–1302. https://doi.org/10.1016/j.kint.2021.07.013.
       Full Text  Link to Item
    • Edmonston, Daniel L., Roland Matsouaka, Svati H. Shah, Sudarshan Rajagopal, and Myles Wolf. “Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload.” Am J Cardiol 159 (November 15, 2021): 113–20. https://doi.org/10.1016/j.amjcard.2021.08.016.
       Full Text  Link to Item
    • Hsu, Chi-Yuan, Wei Yang, Rishi V. Parikh, Amanda H. Anderson, Teresa K. Chen, Debbie L. Cohen, Jiang He, et al. “Race, Genetic Ancestry, and Estimating Kidney Function in CKD.” N Engl J Med 385, no. 19 (November 4, 2021): 1750–60. https://doi.org/10.1056/NEJMoa2103753.
       Full Text  Link to Item
    • Paul, Shejuti, Mandy Wong, Ehimare Akhabue, Rupal C. Mehta, Holly Kramer, Tamara Isakova, Mercedes R. Carnethon, Myles Wolf, and Orlando M. Gutiérrez. “Fibroblast Growth Factor 23 and Incident Cardiovascular Disease and Mortality in Middle-Aged Adults.” J Am Heart Assoc 10, no. 16 (August 17, 2021): e020196. https://doi.org/10.1161/JAHA.120.020196.
       Full Text  Link to Item
    • Courbon, Guillaume, Connor Francis, Claire Gerber, Samantha Neuburg, Xueyan Wang, Emily Lynch, Tamara Isakova, et al. “Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease.” Bone Res 9, no. 1 (August 2, 2021): 35. https://doi.org/10.1038/s41413-021-00154-0.
       Full Text  Link to Item
    • Glaspy, John A., Myles Wolf, and William E. Strauss. “Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.” Adv Ther 38, no. 7 (July 2021): 3531–49. https://doi.org/10.1007/s12325-021-01770-2.
       Full Text  Link to Item
    • Edmonston, Daniel L., Tamara Isakova, Laura M. Dember, Steven Brunelli, Amy Young, Rebecca Brosch, Srinivasan Beddhu, Hrishikesh Chakraborty, and Myles Wolf. “Design and Rationale of HiLo: A Pragmatic, Randomized Trial of Phosphate Management for Patients Receiving Maintenance Hemodialysis.” Am J Kidney Dis 77, no. 6 (June 2021): 920-930.e1. https://doi.org/10.1053/j.ajkd.2020.10.008.
       Full Text  Link to Item
    • Bansal, Nisha, Leila R. Zelnick, Elsayed Z. Soliman, Amanda Anderson, Robert Christenson, Christopher DeFilippi, Rajat Deo, et al. “Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.” Am J Kidney Dis 77, no. 6 (June 2021): 907–19. https://doi.org/10.1053/j.ajkd.2020.09.021.
       Full Text  Link to Item
    • Murray, Susan L., and Myles Wolf. “Pivoting From PTH to FGF23 to Mend Breaking Hearts on Dialysis.” Circ Res 128, no. 11 (May 28, 2021): 1626–28. https://doi.org/10.1161/CIRCRESAHA.121.319306.
       Full Text  Link to Item
    • Bello, A. K., M. McIsaac, I. G. Okpechi, D. W. Johnson, V. Jha, D. C. H. Harris, S. Saad, et al. “International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean.” Kidney International Supplements 11, no. 2 (May 1, 2021): e66–76. https://doi.org/10.1016/j.kisu.2021.01.001.
       Full Text
    • Schaefer, Benedikt, Moritz Tobiasch, André Viveiros, Herbert Tilg, Nicholas A. Kennedy, Myles Wolf, and Heinz Zoller. “Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis.” British Journal of Clinical Pharmacology 87, no. 5 (May 2021): 2256–73. https://doi.org/10.1111/bcp.14643.
       Full Text
    • Gitomer, Berenice, Renata Pereira, Isidro B. Salusky, Jason W. Stoneback, Tamara Isakova, Xuan Cai, Lorien S. Dalrymple, et al. “Mineral bone disease in autosomal dominant polycystic kidney disease.” Kidney Int 99, no. 4 (April 2021): 977–85. https://doi.org/10.1016/j.kint.2020.07.041.
       Full Text  Link to Item
    • Ghuman, Jasleen, Xuan Cai, Ravi B. Patel, Sadiya S. Khan, Jonathan Hecktman, Margaret M. Redfield, Gregory Lewis, et al. “Fibroblast Growth Factor 23 and Exercise Capacity in Heart Failure with Preserved Ejection Fraction.” J Card Fail 27, no. 3 (March 2021): 309–17. https://doi.org/10.1016/j.cardfail.2020.09.477.
       Full Text  Link to Item
    • Anderson, Amanda H., Dawei Xie, Xue Wang, Robin L. Baudier, Paula Orlandi, Lawrence J. Appel, Laura M. Dember, et al. “Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.” Am J Kidney Dis 77, no. 1 (January 2021): 56-73.e1. https://doi.org/10.1053/j.ajkd.2020.07.011.
       Full Text  Link to Item
    • Bhandari, Sunil, Philip A. Kalra, Mario Berkowitz, Diogo Belo, Lars L. Thomsen, and Myles Wolf. “Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.” Nephrol Dial Transplant 36, no. 1 (January 1, 2021): 111–20. https://doi.org/10.1093/ndt/gfaa011.
       Full Text  Link to Item
    • Wolf, Myles, Michael Auerbach, Philip A. Kalra, John Glaspy, Lars L. Thomsen, and Sunil Bhandari. “Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials.” Am J Hematol 96, no. 1 (January 2021): E11–15. https://doi.org/10.1002/ajh.26015.
       Full Text  Link to Item
    • Edmonston, Daniel L., Matthew T. Roe, Geoffrey Block, Paul T. Conway, Laura M. Dember, Peter M. DiBattiste, Tom Greene, et al. “Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.” Am J Kidney Dis 76, no. 6 (December 2020): 842–50. https://doi.org/10.1053/j.ajkd.2020.05.026.
       Full Text  Link to Item
    • Edmonston, Daniel L., Sudarshan Rajagopal, and Myles Wolf. “Echocardiography to Screen for Pulmonary Hypertension in CKD.” Kidney Int Rep 5, no. 12 (December 2020): 2275–83. https://doi.org/10.1016/j.ekir.2020.09.033.
       Full Text  Open Access Copy  Link to Item
    • Frazier, Rebecca, Alexander Hodakowski, Xuan Cai, Jungwha Lee, Anaadriana Zakarija, Brady Stein, Valentin David, Myles Wolf, Tamara Isakova, and Rupal Mehta. “Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.” Bone 141 (December 2020): 115559. https://doi.org/10.1016/j.bone.2020.115559.
       Full Text  Link to Item
    • Anand, Shuchi, Ram Jagannathan, Ruby Gupta, Sailesh Mohan, Dorairaj Prabhakaran, and Myles Wolf. “Fibroblast Growth Factor-23 and a Vegetarian Diet.” Journal of Renal Nutrition : The Official Journal of the Council on Renal Nutrition of the National Kidney Foundation 30, no. 6 (November 2020): 503–8. https://doi.org/10.1053/j.jrn.2020.02.004.
       Full Text
    • Hofacker, Samuel A., Matthew E. Dupre, Kimberly Vellano, Bryan McNally, Monique Anderson Starks, Myles Wolf, Laura P. Svetkey, and Patrick H. Pun. “Association between patient race and staff resuscitation efforts after cardiac arrest in outpatient dialysis clinics: A study from the CARES surveillance group.” Resuscitation 156 (November 2020): 42–50. https://doi.org/10.1016/j.resuscitation.2020.07.036.
       Full Text  Open Access Copy  Link to Item
    • Lentz, Trevor A., Lesley H. Curtis, Frank W. Rockhold, David Martin, Tomas L. G. Andersson, Carolyn Arias, Jesse A. Berlin, et al. “Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting.” Ther Innov Regul Sci 54, no. 6 (November 2020): 1477–88. https://doi.org/10.1007/s43441-020-00175-7.
       Full Text  Link to Item
    • Pool, Lindsay R., Kiarri N. Kershaw, Penny Gordon-Larsen, Orlando M. Gutiérrez, Jared P. Reis, Tamara Isakova, Myles Wolf, and Mercedes R. Carnethon. “Racial Differences in the Associations Between Food Insecurity and Fibroblast Growth Factor 23 in the Coronary Artery Risk Development in Young Adults Study.” J Ren Nutr 30, no. 6 (November 2020): 509–17. https://doi.org/10.1053/j.jrn.2020.01.020.
       Full Text  Link to Item
    • Perelló, Joan, Miquel D. Ferrer, Maria Del Mar Pérez, Nadine Kaesler, Vincent M. Brandenburg, Geert J. Behets, Patrick C. D’Haese, et al. “Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis.” Br J Pharmacol 177, no. 19 (October 2020): 4400–4415. https://doi.org/10.1111/bph.15163.
       Full Text  Link to Item
    • Florenzano, Pablo, Macarena Jimenez, Carlos R. Ferreira, Galina Nesterova, Mary Scott Roberts, Sri Harsha Tella, Luis Fernandez de Castro, et al. “Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23.” J Am Soc Nephrol 31, no. 9 (September 2020): 2184–92. https://doi.org/10.1681/ASN.2019111172.
       Full Text  Link to Item
    • Ishigami, Junichi, Jonathan T. Taliercio, Harold I. Feldman, Anand Srivastava, Raymond R. Townsend, Debbie L. Cohen, Edward J. Horwitz, et al. “Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study.” J Am Soc Nephrol 31, no. 8 (August 2020): 1836–46. https://doi.org/10.1681/ASN.2019101106.
       Full Text  Link to Item
    • Srivastava, Anand, Xuan Cai, Jungwha Lee, Wei Li, Brett Larive, Cynthia Kendrick, Jennifer J. Gassman, et al. “Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD.” Clin J Am Soc Nephrol 15, no. 6 (June 8, 2020): 776–83. https://doi.org/10.2215/CJN.13201019.
       Full Text  Link to Item
    • Mehta, Rupal, Xuan Cai, Jungwha Lee, Dawei Xie, Xue Wang, Julia Scialla, Amanda H. Anderson, et al. “Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.” Am J Kidney Dis 75, no. 6 (June 2020): 908–18. https://doi.org/10.1053/j.ajkd.2019.09.009.
       Full Text  Link to Item
    • Ishigami, Junichi, Jonathan Taliercio, Harold I Feldman, Anand Srivastava, Raymond Townsend, Debbie L Cohen, Edward Horwitz, et al. “Inflammatory Markers and Incidence of Hospitalization With Infection in Chronic Kidney Disease.” Am J Epidemiol 189, no. 5 (May 5, 2020): 433–44. https://doi.org/10.1093/aje/kwz246.
       Full Text  Link to Item
    • Edmonston, Daniel L., Kishan S. Parikh, Sudarshan Rajagopal, Linda K. Shaw, Dennis Abraham, Alexander Grabner, Matthew A. Sparks, and Myles Wolf. “Pulmonary Hypertension Subtypes and Mortality in CKD.” Am J Kidney Dis 75, no. 5 (May 2020): 713–24. https://doi.org/10.1053/j.ajkd.2019.08.027.
       Full Text  Open Access Copy  Link to Item
    • Lucas, Anika, and Myles Wolf. “Health Outcomes With Vitamin D Supplementation-Reply.” Jama 323, no. 16 (April 28, 2020): 1619. https://doi.org/10.1001/jama.2020.2645.
       Full Text  Link to Item
    • Nelson, Adam J., Paolo Raggi, Myles Wolf, Alexander M. Gold, Glenn M. Chertow, and Matthew T. Roe. “Targeting Vascular Calcification in Chronic Kidney Disease.” Jacc. Basic to Translational Science 5, no. 4 (April 2020): 398–412. https://doi.org/10.1016/j.jacbts.2020.02.002.
       Full Text
    • Grabner, Alexander, and Myles Wolf. “Kidney to bone via bedside to bench…and back?” J Clin Invest 130, no. 3 (March 2, 2020): 1106–8. https://doi.org/10.1172/JCI135213.
       Full Text  Link to Item
    • Wolf, Myles, Janet Rubin, Maureen Achebe, Michael J. Econs, Munro Peacock, Erik A. Imel, Lars L. Thomsen, et al. “Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.” Jama 323, no. 5 (February 4, 2020): 432–43. https://doi.org/10.1001/jama.2019.22450.
       Full Text  Link to Item
    • Isakova, Tamara, Xuan Cai, Jungwha Lee, Rupal Mehta, Xiaoming Zhang, Wei Yang, Lisa Nessel, et al. “Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.” Am J Kidney Dis 75, no. 2 (February 2020): 235–44. https://doi.org/10.1053/j.ajkd.2019.07.022.
       Full Text  Link to Item
    • Wolf, Myles, Geoffrey A. Block, Glenn M. Chertow, Kerry Cooper, Bruno Fouqueray, Sharon M. Moe, Yan Sun, Holly Tomlin, Marc Vervloet, and Rainer Oberbauer. “Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis.” Clin Kidney J 13, no. 1 (February 2020): 75–84. https://doi.org/10.1093/ckj/sfz034.
       Full Text  Link to Item
    • Raphael, Kalani L., Tamara Isakova, Joachim H. Ix, Dominic S. Raj, Myles Wolf, Linda F. Fried, Jennifer J. Gassman, et al. “A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial.” J Am Soc Nephrol 31, no. 1 (January 2020): 161–74. https://doi.org/10.1681/ASN.2019030287.
       Full Text  Link to Item
    • Willey, Joshua Z., Yeseon Park Moon, S Ali Husain, Mitchell S. V. Elkind, Ralph L. Sacco, Myles Wolf, Ken Cheung, Clinton B. Wright, and Sumit Mohan. “Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.” Plos One 15, no. 1 (2020): e0226509. https://doi.org/10.1371/journal.pone.0226509.
       Full Text  Link to Item
    • Edmonston, Daniel, and Myles Wolf. “FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.” Nat Rev Nephrol 16, no. 1 (January 2020): 7–19. https://doi.org/10.1038/s41581-019-0189-5.
       Full Text  Link to Item
    • Edmonston, Daniel, Daniel Wojdyla, Rupal Mehta, Xuan Cai, Claudia Lora, Debbie Cohen, Raymond R. Townsend, et al. “Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD.” Am J Kidney Dis 74, no. 6 (December 2019): 771–81. https://doi.org/10.1053/j.ajkd.2019.05.026.
       Full Text  Link to Item
    • Emrich, Insa E., Juliane Dederer, Angelika Kircher, Verena Klemis, Claudia S. Lennartz, Kathrin Untersteller, Stefan Wagenpfeil, Danilo Fliser, Myles Wolf, and Gunnar H. Heine. “Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet?” Nutr Metab Cardiovasc Dis 29, no. 12 (December 2019): 1361–67. https://doi.org/10.1016/j.numecd.2019.09.002.
       Full Text  Link to Item
    • Francis, Connor, Guillaume Courbon, Claire Gerber, Samantha Neuburg, Xueyan Wang, Corey Dussold, Maralee Capella, et al. “Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.” Kidney Int 96, no. 6 (December 2019): 1346–58. https://doi.org/10.1016/j.kint.2019.07.026.
       Full Text  Link to Item
    • Lucas, Anika, and Myles Wolf. “Vitamin D and Health Outcomes: Then Came the Randomized Clinical Trials.” Jama 322, no. 19 (November 19, 2019): 1866–68. https://doi.org/10.1001/jama.2019.17302.
       Full Text  Link to Item
    • Bansal, N., R. Katz, L. J. Appel, M. Denburg, H. Feldman, A. S. Go, J. He, et al. “Vitamin D Metabolic Ratio and Risks of Death and CKD Progression.” Kidney International Reports 4, no. 11 (November 1, 2019): 1598–1607. https://doi.org/10.1016/j.ekir.2019.08.014.
       Full Text
    • Taylor, Ashlee, Christopher Yanucil, John Musgrove, Melody Shi, Shintaro Ide, Tomokazu Souma, Christian Faul, Myles Wolf, and Alexander Grabner. “FGFR4 does not contribute to progression of chronic kidney disease.” Sci Rep 9, no. 1 (October 1, 2019): 14023. https://doi.org/10.1038/s41598-019-50669-0.
       Full Text  Link to Item
    • Musgrove, John, and Myles Wolf. “Editorial: awareness and prevention of intravenous iron-induced hypophosphataemia.” Aliment Pharmacol Ther 50, no. 5 (September 2019): 609–10. https://doi.org/10.1111/apt.15437.
       Full Text  Link to Item
    • Lamprea-Montealegre, Julio A., Leila R. Zelnick, Michael G. Shlipak, James S. Floyd, Amanda H. Anderson, Jiang He, Rob Christenson, et al. “Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study.” J Am Heart Assoc 8, no. 15 (August 6, 2019): e012200. https://doi.org/10.1161/JAHA.119.012200.
       Full Text  Link to Item
    • Block, Geoffrey A., Martha S. Block, Gerard Smits, Rupal Mehta, Tamara Isakova, Myles Wolf, and Glenn M. Chertow. “A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.” J Am Soc Nephrol 30, no. 8 (August 2019): 1495–1504. https://doi.org/10.1681/ASN.2018101016.
       Full Text  Link to Item
    • Brown, Landon, Alison Luciano, Jane Pendergast, Pascale Khairallah, Cheryl A. M. Anderson, James Sondheimer, L Lee Hamm, et al. “Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study.” Am J Kidney Dis 74, no. 2 (August 2019): 203–12. https://doi.org/10.1053/j.ajkd.2018.12.043.
       Full Text  Link to Item
    • Rope, R., J. Perl, S. Anand, K. Kalantar-Zadeh, A. Levin, A. Fogo, A. Cheung, et al. “Global Health Training Opportunities in North American Nephrology Fellowships.” Kidney International Reports 4, no. 7 (July 1, 2019): 904–7. https://doi.org/10.1016/j.ekir.2019.04.019.
       Full Text
    • Paluch, Amanda E., Lindsay R. Pool, Tamara Isakova, Cora E. Lewis, Rupal Mehta, Pamela J. Schreiner, Stephen Sidney, Myles Wolf, and Mercedes R. Carnethon. “Association of Fitness With Racial Differences in Chronic Kidney Disease.” Am J Prev Med 57, no. 1 (July 2019): 68–76. https://doi.org/10.1016/j.amepre.2019.02.016.
       Full Text  Link to Item
    • Yokoyama, Keitaro, Masafumi Fukagawa, Takashi Akiba, Masaaki Nakayama, Kyoko Ito, Koji Hanaki, Myles Wolf, and Hideki Hirakata. “Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study.” Sci Rep 9, no. 1 (June 20, 2019): 8877. https://doi.org/10.1038/s41598-019-45335-4.
       Full Text  Link to Item
    • Bundy, Joshua D., Xuan Cai, Julia J. Scialla, Mirela A. Dobre, Jing Chen, Chi-Yuan Hsu, Mary B. Leonard, et al. “Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study.” Am J Kidney Dis 73, no. 6 (June 2019): 806–14. https://doi.org/10.1053/j.ajkd.2019.01.024.
       Full Text  Link to Item
    • Ix, Joachim H., Tamara Isakova, Brett Larive, Kalani L. Raphael, Dominic S. Raj, Alfred K. Cheung, Stuart M. Sprague, et al. “Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial.” J Am Soc Nephrol 30, no. 6 (June 2019): 1096–1108. https://doi.org/10.1681/ASN.2018101058.
       Full Text  Link to Item
    • Amdur, Richard L., Harold I. Feldman, Elizabeth A. Dominic, Amanda H. Anderson, Srinivasan Beddhu, Mahboob Rahman, Myles Wolf, et al. “Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study.” Am J Kidney Dis 73, no. 3 (March 2019): 344–53. https://doi.org/10.1053/j.ajkd.2018.09.012.
       Full Text  Link to Item
    • Block, Geoffrey A., David P. Rosenbaum, Andrew Yan, Peter J. Greasley, Glenn M. Chertow, and Myles Wolf. “The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.” Nephrol Dial Transplant 34, no. 2 (February 1, 2019): 339–46. https://doi.org/10.1093/ndt/gfy061.
       Full Text  Link to Item
    • Edmonston, Daniel, and Myles Wolf. “Good Guys, Bad Guys, Guesses, and Near Misses in Nephrology.” Clin J Am Soc Nephrol 14, no. 1 (January 7, 2019): 7–9. https://doi.org/10.2215/CJN.13801118.
       Full Text  Link to Item
    • Akhabue, Ehimare, Thanh-Huyen T. Vu, Anand Vaidya, Erin D. Michos, Ian H. de Boer, Bryan Kestenbaum, Matthew Allison, et al. “Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The MESA Study.” Am J Hypertens 32, no. 1 (January 1, 2019): 18–25. https://doi.org/10.1093/ajh/hpy142.
       Full Text  Link to Item
    • Canney, Mark, Ognjenka Djurdjev, Mila Tang, Claudia Zierold, Frank Blocki, Myles Wolf, and Adeera Levin. “GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease.” Am J Nephrol 50, no. 2 (2019): 105–14. https://doi.org/10.1159/000501189.
       Full Text  Link to Item
    • Dussold, Corey, Claire Gerber, Samantha White, Xueyan Wang, Lixin Qi, Connor Francis, Maralee Capella, et al. “DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease.” Bone Res 7 (2019): 12. https://doi.org/10.1038/s41413-019-0051-1.
       Full Text  Link to Item
    • Jovanovich, Anna, Zhiying You, Tamara Isakova, Kristen Nowak, Alfred Cheung, Myles Wolf, Michel Chonchol, and Jessica Kendrick. “Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study.” Am J Nephrol 49, no. 4 (2019): 263–70. https://doi.org/10.1159/000497445.
       Full Text  Link to Item
    • Schrauben, Sarah J., Jesse Y. Hsu, Julie Wright Nunes, Michael J. Fischer, Anand Srivastava, Jing Chen, Jeanne Charleston, et al. “Health Behaviors in Younger and Older Adults With CKD: Results From the CRIC Study.” Kidney Int Rep 4, no. 1 (January 2019): 80–93. https://doi.org/10.1016/j.ekir.2018.09.003.
       Full Text  Link to Item
    • Wolf, Myles, Glenn M. Chertow, Iain C. Macdougall, Robert Kaper, Julie Krop, and William Strauss. “Randomized trial of intravenous iron-induced hypophosphatemia.” Jci Insight 3, no. 23 (December 6, 2018). https://doi.org/10.1172/jci.insight.124486.
       Full Text  Link to Item
    • Kolak, Marynia, Michelle Bradley, Daniel Block, Lindsay Pool, Gaurang Garg, Chrissy Kelly Toman, Kyle Boatright, et al. “Chicago supermarket data and food access analytics in census tract shapefiles for 2007-2014.” Data Brief 21 (December 2018): 2482–88. https://doi.org/10.1016/j.dib.2018.11.014.
       Full Text  Open Access Copy  Link to Item
    • Prasad, Pottumarthi V., Wei Li, Dominic S. Raj, James Carr, Maria Carr, Jon Thacker, Lu-Ping Li, et al. “Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD.” Kidney Int Rep 3, no. 6 (November 2018): 1467–72. https://doi.org/10.1016/j.ekir.2018.07.006.
       Full Text  Link to Item
    • Edmonston, Daniel, Myles Wolf, and Michael Pencina. “Statins at Dialysis Transition-Supportive but Not Sufficient.” Jama Netw Open 1, no. 6 (October 5, 2018): e182411. https://doi.org/10.1001/jamanetworkopen.2018.2411.
       Full Text  Link to Item
    • Robinson-Cohen, Cassianne, Traci M. Bartz, Dongbing Lai, T Alp Ikizler, Munro Peacock, Erik A. Imel, Erin D. Michos, et al. “Genetic Variants Associated with Circulating Fibroblast Growth Factor 23.” J Am Soc Nephrol 29, no. 10 (October 2018): 2583–92. https://doi.org/10.1681/ASN.2018020192.
       Full Text  Link to Item
    • Mehta, Rupal, Xuan Cai, Alexander Hodakowski, Bharat Thyagarajan, Donglin Zeng, Phyllis C. Zee, William K. Wohlgemuth, et al. “Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos.” Bone 114 (September 2018): 278–84. https://doi.org/10.1016/j.bone.2018.06.024.
       Full Text  Link to Item
    • Scialla, Julia J., Landon Brown, Susan Gurley, David L. Corcoran, James R. Bain, Michael J. Muehlbauer, Sara K. O’Neal, et al. “Metabolic Changes with Base-Loading in CKD.” Clin J Am Soc Nephrol 13, no. 8 (August 7, 2018): 1244–46. https://doi.org/10.2215/CJN.01830218.
       Full Text  Open Access Copy  Link to Item
    • Akhabue, Ehimare, Samantha Montag, Jared P. Reis, Lindsay R. Pool, Rupal Mehta, Clyde W. Yancy, Lihui Zhao, et al. “FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study.” Hypertension 72, no. 1 (July 2018): 70–76. https://doi.org/10.1161/HYPERTENSIONAHA.118.11060.
       Full Text  Link to Item
    • Kolak, Marynia, Michelle Bradley, Daniel R. Block, Lindsay Pool, Gaurang Garg, Chrissy Kelly Toman, Kyle Boatright, et al. “Urban foodscape trends: Disparities in healthy food access in Chicago, 2007-2014.” Health Place 52 (July 2018): 231–39. https://doi.org/10.1016/j.healthplace.2018.06.003.
       Full Text  Link to Item
    • Gerber, Claire, Xuan Cai, Jungwha Lee, Timothy Craven, Julia Scialla, Nao Souma, Anand Srivastava, et al. “Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes.” Clin J Am Soc Nephrol 13, no. 6 (June 7, 2018): 884–92. https://doi.org/10.2215/CJN.11871017.
       Full Text  Link to Item
    • Leaf, David E., Edward D. Siew, Michele F. Eisenga, Karandeep Singh, Finnian R. Mc Causland, Anand Srivastava, T Alp Ikizler, et al. “Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients.” Clin J Am Soc Nephrol 13, no. 4 (April 6, 2018): 531–41. https://doi.org/10.2215/CJN.10810917.
       Full Text  Link to Item
    • Nakayama, Masaaki, Yoshihiro Tani, Wan-Jun Zhu, Kimio Watanabe, Keitaro Yokoyama, Masafumi Fukagawa, Takashi Akiba, Myles Wolf, and Hideki Hirakata. “Oral Ferric Citrate Hydrate Associated With Less Oxidative Stress Than Intravenous Saccharated Ferric Oxide.” Kidney Int Rep 3, no. 2 (March 2018): 364–73. https://doi.org/10.1016/j.ekir.2017.10.016.
       Full Text  Link to Item
    • Isakova, Tamara, Xuan Cai, Jungwha Lee, Dawei Xie, Xue Wang, Rupal Mehta, Norrina B. Allen, et al. “Longitudinal FGF23 Trajectories and Mortality in Patients with CKD.” J Am Soc Nephrol 29, no. 2 (February 2018): 579–90. https://doi.org/10.1681/ASN.2017070772.
       Full Text  Link to Item
    • Mitsnefes, Mark M., Aisha Betoko, Michael F. Schneider, Isidro B. Salusky, Myles Selig Wolf, Harald Jüppner, Bradley A. Warady, Susan L. Furth, and Anthony A. Portale. “FGF23 and Left Ventricular Hypertrophy in Children with CKD.” Clin J Am Soc Nephrol 13, no. 1 (January 6, 2018): 45–52. https://doi.org/10.2215/CJN.02110217.
       Full Text  Link to Item
    • Husain, S Ali, Joshua Z. Willey, Yeseon Park Moon, Mitchell S. V. Elkind, Ralph L. Sacco, Myles Wolf, Ken Cheung, Clinton B. Wright, and Sumit Mohan. “Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study.” Plos One 13, no. 11 (2018): e0206839. https://doi.org/10.1371/journal.pone.0206839.
       Full Text  Open Access Copy  Link to Item
    • Wagener, E. D. A., N. Souma, A. Hodakowski, C. Martinez, P. Fox, R. Mehta, M. J. O’Brien, et al. “A Patient With CKD Develops Cholestatic Liver Injury During a Clinical Trial.” Kidney International Reports 3, no. 1 (January 1, 2018): 5–10. https://doi.org/10.1016/j.ekir.2017.07.012.
       Full Text
    • Marebwa, Barbara K., Robert J. Adams, Gayenell S. Magwood, Mark Kindy, Janina Wilmskoetter, Myles Wolf, and Leonardo Bonilha. “Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes.” Plos One 13, no. 9 (2018): e0203460. https://doi.org/10.1371/journal.pone.0203460.
       Full Text  Open Access Copy  Link to Item
    • Ishigami, Junichi, Bernard G. Jaar, Casey M. Rebholz, Morgan E. Grams, Erin D. Michos, Myles Wolf, Csaba P. Kovesdy, et al. “Biomarkers of Mineral and Bone Metabolism and 20-Year Risk of Hospitalization With Infection: The Atherosclerosis Risk in Communities Study.” J Clin Endocrinol Metab 102, no. 12 (December 1, 2017): 4648–57. https://doi.org/10.1210/jc.2017-01868.
       Full Text  Link to Item
    • Mehta, Rupal, Xuan Cai, Alexander Hodakowski, Jungwha Lee, Mary Leonard, Ana Ricardo, Jing Chen, et al. “Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study.” Clin J Am Soc Nephrol 12, no. 11 (November 7, 2017): 1795–1803. https://doi.org/10.2215/CJN.03950417.
       Full Text  Link to Item
    • Kosk, Dominique, Holly Kramer, Amy Luke, Pauline Camacho, Pascal Bovet, Jacob Plange Rhule, Terrence Forrester, et al. “Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry.” J Bone Miner Metab 35, no. 6 (November 2017): 666–74. https://doi.org/10.1007/s00774-016-0804-5.
       Full Text  Link to Item
    • Khairallah, Pascale, Tamara Isakova, John Asplin, Lee Hamm, Mirela Dobre, Mahboob Rahman, Kumar Sharma, et al. “Acid Load and Phosphorus Homeostasis in CKD.” Am J Kidney Dis 70, no. 4 (October 2017): 541–50. https://doi.org/10.1053/j.ajkd.2017.04.022.
       Full Text  Link to Item
    • Batacchi, Zona, Cassianne Robinson-Cohen, Andrew N. Hoofnagle, Tamara Isakova, Bryan Kestenbaum, Kevin J. Martin, Myles S. Wolf, and Ian H. de Boer. “Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD.” Clin J Am Soc Nephrol 12, no. 9 (September 7, 2017): 1498–1506. https://doi.org/10.2215/CJN.00530117.
       Full Text  Link to Item
    • Chonchol, Michel, Berenice Gitomer, Tamara Isakova, Xuan Cai, Isidro Salusky, Renata Pereira, Kaleab Abebe, et al. “Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease.” Clin J Am Soc Nephrol 12, no. 9 (September 7, 2017): 1461–69. https://doi.org/10.2215/CJN.12821216.
       Full Text  Link to Item
    • Schaefer, B., B. Glodny, M. Wolf, and H. Zoller. “Letter: inconsistency in reporting of hypophosphatemia after intravenous iron.” Aliment Pharmacol Ther 46, no. 6 (September 2017): 641–43. https://doi.org/10.1111/apt.14231.
       Full Text  Link to Item
    • Pichler, Gernot, Maria C. Haller, Alexander Kainz, Myles Wolf, Josep Redon, and Rainer Oberbauer. “Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis.” Nephrol Dial Transplant 32, no. 9 (September 1, 2017): 1566–78. https://doi.org/10.1093/ndt/gfw387.
       Full Text  Link to Item
    • Ahmad, Faraz S., Xuan Cai, Katherine Kunkel, Ana C. Ricardo, James P. Lash, Dominic S. Raj, Jiang He, et al. “Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort.” Am J Hypertens 30, no. 8 (August 1, 2017): 822–29. https://doi.org/10.1093/ajh/hpx058.
       Full Text  Link to Item
    • Hsu, Jesse Yenchih, Jason A. Roy, Dawei Xie, Wei Yang, Haochang Shou, Amanda Hyre Anderson, J Richard Landis, et al. “Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.” Clin J Am Soc Nephrol 12, no. 7 (July 7, 2017): 1181–89. https://doi.org/10.2215/CJN.10301016.
       Full Text  Link to Item
    • Wolf, Myles, and David A. Bushinsky. “Something old, something new, something borrowed, something black.” Curr Opin Nephrol Hypertens 26, no. 4 (July 2017): 241–42. https://doi.org/10.1097/MNH.0000000000000325.
       Full Text  Link to Item
    • Kim, Seok-Jo, Paul Cheresh, Mesut Eren, Renea P. Jablonski, Anjana Yeldandi, Karen M. Ridge, GR Scott Budinger, et al. “Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis.” Am J Physiol Lung Cell Mol Physiol 313, no. 1 (July 1, 2017): L16–26. https://doi.org/10.1152/ajplung.00063.2017.
       Full Text  Link to Item
    • Chen, Jing, Matthew J. Budoff, Muredach P. Reilly, Wei Yang, Sylvia E. Rosas, Mahboob Rahman, Xiaoming Zhang, et al. “Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.” Jama Cardiol 2, no. 6 (June 1, 2017): 635–43. https://doi.org/10.1001/jamacardio.2017.0363.
       Full Text  Link to Item
    • Leaf, David E., Kirolos A. Jacob, Anand Srivastava, Margaret E. Chen, Marta Christov, Harald Jüppner, Venkata S. Sabbisetti, Aline Martin, Myles Wolf, and Sushrut S. Waikar. “Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness.” J Am Soc Nephrol 28, no. 6 (June 2017): 1877–85. https://doi.org/10.1681/ASN.2016080836.
       Full Text  Link to Item
    • Scialla, Julia J., John Asplin, Myles Wolf, and Myles Chronic Renal Insufficiency Cohort Study Investigators. “The Authors Reply.” Kidney Int 91, no. 6 (June 2017): 1518–19. https://doi.org/10.1016/j.kint.2017.02.020.
       Full Text  Link to Item
    • He, Jiang, Michael Shlipak, Amanda Anderson, Jason A. Roy, Harold I. Feldman, Radhakrishna Reddy Kallem, Radhika Kanthety, et al. “Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study.” J Am Heart Assoc 6, no. 5 (May 17, 2017). https://doi.org/10.1161/JAHA.116.005336.
       Full Text  Open Access Copy  Link to Item
    • Grabner, Alexander, Karla Schramm, Neerupma Silswal, Matt Hendrix, Christopher Yanucil, Brian Czaya, Saurav Singh, et al. “FGF23/FGFR4-mediated left ventricular hypertrophy is reversible.” Sci Rep 7, no. 1 (May 16, 2017): 1993. https://doi.org/10.1038/s41598-017-02068-6.
       Full Text  Open Access Copy  Link to Item
    • Robinson-Cohen, Cassianne, Pamela L. Lutsey, Marcus E. Kleber, Carrie M. Nielson, Braxton D. Mitchell, Joshua C. Bis, Karen M. Eny, et al. “Genetic Variants Associated with Circulating Parathyroid Hormone.” J Am Soc Nephrol 28, no. 5 (May 2017): 1553–65. https://doi.org/10.1681/ASN.2016010069.
       Full Text  Link to Item
    • Munoz Mendoza, Jair, Tamara Isakova, Xuan Cai, Liz Y. Bayes, Christian Faul, Julia J. Scialla, James P. Lash, et al. “Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.” Kidney Int 91, no. 3 (March 2017): 711–19. https://doi.org/10.1016/j.kint.2016.10.021.
       Full Text  Link to Item
    • Resende, Aline L., Rosilene M. Elias, Myles Wolf, Luciene M. Dos Reis, Fabiana G. Graciolli, Geuza D. Santos, Cristiane B. Dias, Vanda Jorgetti, Viktoria Woronik, and Rosa M. A. Moysés. “Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis.” Cytokine 91 (March 2017): 124–27. https://doi.org/10.1016/j.cyto.2016.12.022.
       Full Text  Link to Item
    • Middleton, John P., and Myles Wolf. “Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic.” Jama 317, no. 2 (January 10, 2017): 139–41. https://doi.org/10.1001/jama.2016.18631.
       Full Text  Link to Item
    • Scialla, Julia J., John Asplin, Mirela Dobre, Alex R. Chang, James Lash, Chi-Yuan Hsu, Radhakrishna R. Kallem, et al. “Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.” Kidney Int 91, no. 1 (January 2017): 204–15. https://doi.org/10.1016/j.kint.2016.09.012.
       Full Text  Link to Item
    • Portale, Anthony A., Myles S. Wolf, Shari Messinger, Farzana Perwad, Harald Jüppner, Bradley A. Warady, Susan L. Furth, and Isidro B. Salusky. “Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.” Clin J Am Soc Nephrol 11, no. 11 (November 7, 2016): 1989–98. https://doi.org/10.2215/CJN.02110216.
       Full Text  Link to Item
    • Bonato, F. O. B., R. Watanabe, M. Montebello Lemos, J. L. Cassiolato, M. Wolf, and M. E. F. Canziani. “Asymptomatic ventricular arrhythmia and clinical outcomes in chronic kidney disease: A pilot study.” Cardiorenal Medicine 7, no. 1 (November 1, 2016): 66–73. https://doi.org/10.1159/000449260.
       Full Text
    • Singh, Saurav, Alexander Grabner, Christopher Yanucil, Karla Schramm, Brian Czaya, Stefanie Krick, Mark J. Czaja, et al. “Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.” Kidney Int 90, no. 5 (November 2016): 985–96. https://doi.org/10.1016/j.kint.2016.05.019.
       Full Text  Link to Item
    • Lash, James P., Ana C. Ricardo, Jason Roy, Rajat Deo, Michael Fischer, John Flack, Jiang He, et al. “Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies.” Am J Kidney Dis 68, no. 4 (October 2016): 545–53. https://doi.org/10.1053/j.ajkd.2016.03.429.
       Full Text  Link to Item
    • Souma, Nao, Tamara Isakova, David Lipiszko, Ralph L. Sacco, Mitchell S. V. Elkind, Janet T. DeRosa, Shonni J. Silverberg, et al. “Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study.” J Clin Endocrinol Metab 101, no. 10 (October 2016): 3779–86. https://doi.org/10.1210/jc.2016-2215.
       Full Text  Link to Item
    • Mehta, Rupal, Xuan Cai, Jungwha Lee, Julia J. Scialla, Nisha Bansal, James H. Sondheimer, Jing Chen, et al. “Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.” Jama Cardiol 1, no. 5 (August 1, 2016): 548–56. https://doi.org/10.1001/jamacardio.2016.1445.
       Full Text  Link to Item
    • Bansal, Nisha, Dawei Xie, Kelvin Tao, Jing Chen, Rajat Deo, Edward Horwitz, Chi-Yuan Hsu, et al. “Atrial Fibrillation and Risk of ESRD in Adults with CKD.” Clin J Am Soc Nephrol 11, no. 7 (July 7, 2016): 1189–96. https://doi.org/10.2215/CJN.10921015.
       Full Text  Link to Item
    • Bushinsky, D. A., and M. Wolf. “Mineral metabolism: Progress in the face of complexity.” Current Opinion in Nephrology and Hypertension 25, no. 4 (July 1, 2016): 269–70. https://doi.org/10.1097/MNH.0000000000000242.
       Full Text
    • Yuen, Shennin N., Holly Kramer, Amy Luke, Pascal Bovet, Jacob Plange-Rhule, Terrence Forrester, Vicki Lambert, et al. “Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization.” J Clin Endocrinol Metab 101, no. 5 (May 2016): 2246–53. https://doi.org/10.1210/jc.2015-3558.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Afshin Parsa, Tamara Isakova, Julia J. Scialla, Jing Chen, John M. Flack, Lisa C. Nessel, et al. “Genetic African Ancestry and Markers of Mineral Metabolism in CKD.” Clin J Am Soc Nephrol 11, no. 4 (April 7, 2016): 653–62. https://doi.org/10.2215/CJN.08020715.
       Full Text  Link to Item
    • Ali, Farah N., Jami Josefson, Armando J. Mendez, Karen Mestan, and Myles Wolf. “Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates.” J Clin Endocrinol Metab 101, no. 4 (April 2016): 1673–79. https://doi.org/10.1210/jc.2015-3709.
       Full Text  Link to Item
    • Leaf, David E., Marta Christov, Harald Jüppner, Edward Siew, T Alp Ikizler, Aihua Bian, Guanhua Chen, et al. “Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery.” Kidney Int 89, no. 4 (April 2016): 939–48. https://doi.org/10.1016/j.kint.2015.12.035.
       Full Text  Link to Item
    • Wright, Clinton B., Nirav H. Shah, Armando J. Mendez, Janet T. DeRosa, Mitsuhiro Yoshita, Mitchell S. V. Elkind, Ralph L. Sacco, et al. “Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.” Stroke 47, no. 4 (April 2016): 923–28. https://doi.org/10.1161/STROKEAHA.115.012379.
       Full Text  Link to Item
    • Wald, Ron, Marc B. Goldstein, Jeffrey Perl, Mercedeh Kiaii, Darren Yuen, Rachel M. Wald, Ziv Harel, et al. “The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease.” Can J Cardiol 32, no. 3 (March 2016): 369–77. https://doi.org/10.1016/j.cjca.2015.07.004.
       Full Text  Link to Item
    • David, Valentin, and Myles Wolf. “Pruning the ricket thicket.” J Clin Invest 126, no. 2 (February 2016): 473–76. https://doi.org/10.1172/JCI85005.
       Full Text  Link to Item
    • David, Valentin, Aline Martin, Tamara Isakova, Christina Spaulding, Lixin Qi, Veronica Ramirez, Kimberly B. Zumbrennen-Bullough, et al. “Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production.” Kidney Int 89, no. 1 (January 2016): 135–46. https://doi.org/10.1038/ki.2015.290.
       Full Text  Link to Item
    • Chen, Teresa K., Michael J. Choi, WH Linda Kao, Brad C. Astor, Julia J. Scialla, Lawrence J. Appel, Liang Li, et al. “Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.” Clin J Am Soc Nephrol 10, no. 12 (December 7, 2015): 2128–35. https://doi.org/10.2215/CJN.05220515.
       Full Text  Link to Item
    • Suarez, Jonathan J., Tamara Isakova, Cheryl A. M. Anderson, L Ebony Boulware, Myles Wolf, and Julia J. Scialla. “Food Access, Chronic Kidney Disease, and Hypertension in the U.S.” Am J Prev Med 49, no. 6 (December 2015): 912–20. https://doi.org/10.1016/j.amepre.2015.07.017.
       Full Text  Link to Item
    • Grabner, Alexander, Ansel P. Amaral, Karla Schramm, Saurav Singh, Alexis Sloan, Christopher Yanucil, Jihe Li, et al. “Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.” Cell Metab 22, no. 6 (December 1, 2015): 1020–32. https://doi.org/10.1016/j.cmet.2015.09.002.
       Full Text  Link to Item
    • Faul, Christian, and Myles Wolf. “Hunt for the culprit of cardiovascular injury in kidney disease.” Cardiovasc Res 108, no. 2 (November 1, 2015): 209–11. https://doi.org/10.1093/cvr/cvv228.
       Full Text  Link to Item
    • Wolf, Myles. “Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014.” Clin J Am Soc Nephrol 10, no. 10 (October 7, 2015): 1875–85. https://doi.org/10.2215/CJN.04430415.
       Full Text  Link to Item
    • Wolf, Myles, and Rupal Mehta. “Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure.” Jacc Heart Fail 3, no. 10 (October 2015): 840–42. https://doi.org/10.1016/j.jchf.2015.07.008.
       Full Text  Link to Item
    • Isakova, Tamara, Joachim H. Ix, Stuart M. Sprague, Kalani L. Raphael, Linda Fried, Jennifer J. Gassman, Dominic Raj, et al. “Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.” J Am Soc Nephrol 26, no. 10 (October 2015): 2328–39. https://doi.org/10.1681/ASN.2015020117.
       Full Text  Link to Item
    • Mehta, Rupal, Gui Shuang Ying, Samuel Houston, Tamara Isakova, Lisa Nessel, Akinlolu Ojo, Alan Go, et al. “Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study.” Nephrol Dial Transplant 30, no. 9 (September 2015): 1534–41. https://doi.org/10.1093/ndt/gfv123.
       Full Text  Link to Item
    • Shah, Nirav H., Chuanhui Dong, Mitchell S. V. Elkind, Ralph L. Sacco, Armando J. Mendez, Barry I. Hudson, Shonni Silverberg, Myles Wolf, Tatjana Rundek, and Clinton B. Wright. “Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study.” Arterioscler Thromb Vasc Biol 35, no. 9 (September 2015): 2048–53. https://doi.org/10.1161/ATVBAHA.115.305945.
       Full Text  Link to Item
    • Da, Jingjing, Xinfang Xie, Myles Wolf, Sinee Disthabanchong, Jinwei Wang, Yan Zha, Jicheng Lv, Luxia Zhang, and Haiyan Wang. “Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.” Am J Kidney Dis 66, no. 2 (August 2015): 258–65. https://doi.org/10.1053/j.ajkd.2015.01.009.
       Full Text  Link to Item
    • Scialla, Julia J., and Myles Wolf. “When there will never be a randomized controlled trial.” Kidney Int 88, no. 2 (August 2015): 220–22. https://doi.org/10.1038/ki.2015.123.
       Full Text  Link to Item
    • Wolf, Myles, and David A. Bushinsky. “Bones and stones, edition 2015.” Curr Opin Nephrol Hypertens 24, no. 4 (July 2015): 301–2. https://doi.org/10.1097/MNH.0000000000000143.
       Full Text  Link to Item
    • Hu, Ming Chang, Mingjun Shi, Han Jun Cho, Beverley Adams-Huet, Jean Paek, Kathy Hill, John Shelton, et al. “Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.” J Am Soc Nephrol 26, no. 6 (June 2015): 1290–1302. https://doi.org/10.1681/ASN.2014050465.
       Full Text  Link to Item
    • Block, Geoffrey A., Steven Fishbane, Mariano Rodriguez, Gerard Smits, Shay Shemesh, Pablo E. Pergola, Myles Wolf, and Glenn M. Chertow. “A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.” Am J Kidney Dis 65, no. 5 (May 2015): 728–36. https://doi.org/10.1053/j.ajkd.2014.10.014.
       Full Text  Link to Item
    • Dobre, Mirela, Wei Yang, Qiang Pan, Lawrence Appel, Keith Bellovich, Jing Chen, Harold Feldman, et al. “Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.” J Am Heart Assoc 4, no. 4 (April 20, 2015). https://doi.org/10.1161/JAHA.114.001599.
       Full Text  Open Access Copy  Link to Item
    • Bansal, Nisha, Amanda Hyre Anderson, Wei Yang, Robert H. Christenson, Christopher R. deFilippi, Rajat Deo, Daniel L. Dries, et al. “High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.” J Am Soc Nephrol 26, no. 4 (April 2015): 946–56. https://doi.org/10.1681/ASN.2014010108.
       Full Text  Link to Item
    • Eckberg, Karl, Holly Kramer, Myles Wolf, Ramon Durazo-Arvizu, Bamidele Tayo, Amy Luke, and Richard Cooper. “Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry.” Nephrol Dial Transplant 30, no. 4 (April 2015): 630–35. https://doi.org/10.1093/ndt/gfu342.
       Full Text  Link to Item
    • Arora, Pankaj, Yanna Song, Jeffery Dusek, Gregory Plotnikoff, Marc S. Sabatine, Susan Cheng, Andre Valcour, et al. “Vitamin D therapy in individuals with prehypertension or hypertension: the DAYLIGHT trial.” Circulation 131, no. 3 (January 20, 2015): 254–62. https://doi.org/10.1161/CIRCULATIONAHA.114.011732.
       Full Text  Link to Item
    • Isakova, Tamara, Timothy E. Craven, Jungwha Lee, Julia J. Scialla, Huiliang Xie, Patricia Wahl, Santica M. Marcovina, Robert P. Byington, and Myles Wolf. “Fibroblast growth factor 23 and incident CKD in type 2 diabetes.” Clin J Am Soc Nephrol 10, no. 1 (January 7, 2015): 29–38. https://doi.org/10.2215/CJN.06190614.
       Full Text  Link to Item
    • Bansal, N., H. A. Anderson, W. Yang, R. H. Christenson, C. R. Defilippi, R. Deo, D. L. Dries, et al. “High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) study.” Nieren  Und Hochdruckkrankheiten 44, no. 2 (January 1, 2015): 111.
    • Wolf, Myles. “The biomarker niche for fibroblast growth factor 23 testing in CKD.” J Am Soc Nephrol 26, no. 1 (January 2015): 7–9. https://doi.org/10.1681/ASN.2014060621.
       Full Text  Link to Item
    • Di Marco, Giovana Seno, Stefan Reuter, Dominik Kentrup, Alexander Grabner, Ansel Philip Amaral, Manfred Fobker, Jörg Stypmann, et al. “Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD.” Nephrol Dial Transplant 29, no. 11 (November 2014): 2028–35. https://doi.org/10.1093/ndt/gfu190.
       Full Text  Link to Item
    • Wolf, Myles. “In search of the fountain of youth.” J Am Soc Nephrol 25, no. 10 (October 2014): 2143–45. https://doi.org/10.1681/ASN.2014040392.
       Full Text  Link to Item
    • Bernstein, Elana J., Tamara Isakova, Mary E. Sullivan, Lori B. Chibnik, Myles Wolf, and Jonathan Kay. “Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study.” Rheumatology (Oxford) 53, no. 9 (September 2014): 1613–17. https://doi.org/10.1093/rheumatology/keu151.
       Full Text  Link to Item
    • Bushinsky, David A., and Myles Wolf. “The pursuit of truth and beauty.” Curr Opin Nephrol Hypertens 23, no. 4 (July 2014): 329–30. https://doi.org/10.1097/01.mnh.0000447025.97464.ea.
       Full Text  Link to Item
    • Wolf, Myles, and Kenneth E. White. “Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease.” Curr Opin Nephrol Hypertens 23, no. 4 (July 2014): 411–19. https://doi.org/10.1097/01.mnh.0000447020.74593.6f.
       Full Text  Link to Item
    • Wright, Clinton B., Chuanhui Dong, Matthew Stark, Shonni Silverberg, Tatjana Rundek, Mitchell S. V. Elkind, Ralph L. Sacco, Armando Mendez, and Myles Wolf. “Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS).” Neurology 82, no. 19 (May 13, 2014): 1700–1706. https://doi.org/10.1212/WNL.0000000000000410.
       Full Text  Link to Item
    • Mariani, Laura H., Matthew T. White, Justine Shults, Cheryl A. M. Anderson, Harold I. Feldman, Myles Wolf, Peter P. Reese, et al. “Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study.” J Ren Nutr 24, no. 3 (May 2014): 186–93. https://doi.org/10.1053/j.jrn.2014.01.015.
       Full Text  Link to Item
    • Scialla, Julia J., and Myles Wolf. “Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.” Nat Rev Nephrol 10, no. 5 (May 2014): 268–78. https://doi.org/10.1038/nrneph.2014.49.
       Full Text  Link to Item
    • Portale, Anthony A., Myles Wolf, Harald Jüppner, Shari Messinger, Juhi Kumar, Katherine Wesseling-Perry, George J. Schwartz, Susan L. Furth, Bradley A. Warady, and Isidro B. Salusky. “Disordered FGF23 and mineral metabolism in children with CKD.” Clin J Am Soc Nephrol 9, no. 2 (February 2014): 344–53. https://doi.org/10.2215/CJN.05840513.
       Full Text  Link to Item
    • Scialla, Julia J., Huiliang Xie, Mahboob Rahman, Amanda Hyre Anderson, Tamara Isakova, Akinlolu Ojo, Xiaoming Zhang, et al. “Fibroblast growth factor-23 and cardiovascular events in CKD.” J Am Soc Nephrol 25, no. 2 (February 2014): 349–60. https://doi.org/10.1681/ASN.2013050465.
       Full Text  Link to Item
    • Wald, Ron, Marc B. Goldstein, Rachel M. Wald, Ziv Harel, Anish Kirpalani, Jeffrey Perl, Darren A. Yuen, Myles S. Wolf, and Andrew T. Yan. “Correlates of left ventricular mass in chronic hemodialysis recipients.” Int J Cardiovasc Imaging 30, no. 2 (February 2014): 349–56. https://doi.org/10.1007/s10554-013-0337-0.
       Full Text  Link to Item
    • “Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.” Nature Reviews Nephrology 10, no. 5 (January 1, 2014): 268–78. https://doi.org/10.1038/nrneph201449.
       Full Text
    • Dubin, Ruth F., Yongmei Li, Jiang He, Bernard G. Jaar, Radhakrishna Kallem, James P. Lash, Gail Makos, et al. “Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC).” Bmc Nephrol 14 (October 22, 2013): 229. https://doi.org/10.1186/1471-2369-14-229.
       Full Text  Link to Item
    • Christov, Marta, Sushrut S. Waikar, Renata C. Pereira, Andrea Havasi, David E. Leaf, David Goltzman, Paola D. Pajevic, Myles Wolf, and Harald Jüppner. “Plasma FGF23 levels increase rapidly after acute kidney injury.” Kidney Int 84, no. 4 (October 2013): 776–85. https://doi.org/10.1038/ki.2013.150.
       Full Text  Link to Item
    • Dobre, Mirela, Wei Yang, Jing Chen, Paul Drawz, L Lee Hamm, Edward Horwitz, Thomas Hostetter, et al. “Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.” Am J Kidney Dis 62, no. 4 (October 2013): 670–78. https://doi.org/10.1053/j.ajkd.2013.01.017.
       Full Text  Link to Item
    • Leaf, David E., Sushrut S. Waikar, Myles Wolf, Serge Cremers, Ishir Bhan, and Leonard Stern. “Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes.” Clin Endocrinol (Oxf) 79, no. 4 (October 2013): 491–98. https://doi.org/10.1111/cen.12172.
       Full Text  Link to Item
    • Block, Geoffrey A., Joachim H. Ix, Markus Ketteler, Kevin J. Martin, Ravi I. Thadhani, Marcello Tonelli, Myles Wolf, Harald Jüppner, Keith Hruska, and David C. Wheeler. “Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation.” Am J Kidney Dis 62, no. 3 (September 2013): 457–73. https://doi.org/10.1053/j.ajkd.2013.03.042.
       Full Text  Link to Item
    • Wolf, Myles, Todd A. Koch, and David B. Bregman. “Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 28, no. 8 (August 2013): 1793–1803. https://doi.org/10.1002/jbmr.1923.
       Full Text
    • Wolf, Myles, and David A. Bushinsky. “Innovations in bones and stones.” Curr Opin Nephrol Hypertens 22, no. 4 (July 2013): 369–70. https://doi.org/10.1097/MNH.0b013e3283622bd4.
       Full Text  Link to Item
    • Ky, Bonnie, Justine Shults, Martin G. Keane, Martin St John Sutton, Myles Wolf, Harold I. Feldman, Peter P. Reese, et al. “FGF23 modifies the relationship between vitamin D and cardiac remodeling.” Circ Heart Fail 6, no. 4 (July 2013): 817–24. https://doi.org/10.1161/CIRCHEARTFAILURE.112.000105.
       Full Text  Link to Item
    • Rangel, M. L., I. Alghamdi, G. Contreras, T. Harrington, D. B. Thomas, L. Barisoni, D. Andrews, M. Wolf, A. Asif, and A. Nayer. “Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations.” Lupus 22, no. 8 (July 2013): 855–64. https://doi.org/10.1177/0961203313491024.
       Full Text  Open Access Copy  Link to Item
    • Isakova, Tamara, Allison Barchi-Chung, Gwen Enfield, Kelsey Smith, Gabriella Vargas, Jessica Houston, Huiliang Xie, et al. “Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.” Clin J Am Soc Nephrol 8, no. 6 (June 2013): 1009–18. https://doi.org/10.2215/CJN.09250912.
       Full Text  Link to Item
    • Scialla, Julia J., Wei Ling Lau, Muredach P. Reilly, Tamara Isakova, Hsueh-Ying Yang, Matthew H. Crouthamel, Nicholas W. Chavkin, et al. “Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.” Kidney Int 83, no. 6 (June 2013): 1159–68. https://doi.org/10.1038/ki.2013.3.
       Full Text  Open Access Copy  Link to Item
    • Ketteler, Markus, Myles Wolf, Kai Hahn, and Eberhard Ritz. “Phosphate: a novel cardiovascular risk factor.” Eur Heart J 34, no. 15 (April 2013): 1099–1101. https://doi.org/10.1093/eurheartj/ehs247.
       Full Text  Link to Item
    • Wolf, Myles. “Contemporary mineral metabolism for clinicians and scientists: introduction.” Semin Nephrol 33, no. 2 (March 2013): 91–92. https://doi.org/10.1016/j.semnephrol.2012.12.010.
       Full Text  Link to Item
    • Leaf, David E., and Myles Wolf. “A physiologic-based approach to the evaluation of a patient with hyperphosphatemia.” Am J Kidney Dis 61, no. 2 (February 2013): 330–36. https://doi.org/10.1053/j.ajkd.2012.06.026.
       Full Text  Link to Item
    • Evenepoel, P., and M. Wolf. “A balanced view of calcium and phosphate homeostasis in chronic kidney disease.” Kidney International 83, no. 5 (January 1, 2013): 789–91. https://doi.org/10.1038/ki.2013.21.
       Full Text
    • Isakova, T., H. Xie, S. Messinger, F. Cortazar, J. J. Scialla, G. Guerra, G. Contreras, et al. “Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.” Am J Transplant 13, no. 1 (January 2013): 100–110. https://doi.org/10.1111/j.1600-6143.2012.04281.x.
       Full Text  Link to Item
    • Houston, Jessica, Kelsey Smith, Tamara Isakova, Nicole Sowden, Myles Wolf, and Orlando M. Gutiérrez. “Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease.” J Ren Nutr 23, no. 1 (January 2013): 12–20. https://doi.org/10.1053/j.jrn.2011.12.009.
       Full Text  Link to Item
    • Scialla, Julia J., Brad C. Astor, Tamara Isakova, Huiliang Xie, Lawrence J. Appel, and Myles Wolf. “Mineral metabolites and CKD progression in African Americans.” J Am Soc Nephrol 24, no. 1 (January 2013): 125–35. https://doi.org/10.1681/ASN.2012070713.
       Full Text  Link to Item
    • Smith, Kelsey, Christopher deFilippi, Tamara Isakova, Orlando M. Gutiérrez, Karen Laliberte, Stephen Seliger, Walter Kelley, et al. “Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.” Am J Kidney Dis 61, no. 1 (January 2013): 67–73. https://doi.org/10.1053/j.ajkd.2012.06.022.
       Full Text  Link to Item
    • Ciancio, G., J. Sageshima, L. Chen, J. J. Gaynor, L. Hanson, L. Tueros, E. Montenora-Velarde, et al. “Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years.” Am J Transplant 12, no. 12 (December 2012): 3363–76. https://doi.org/10.1111/j.1600-6143.2012.04235.x.
       Full Text  Link to Item
    • Jüppner, Harald, and Myles Wolf. “αKlotho: FGF23 coreceptor and FGF23-regulating hormone.” J Clin Invest 122, no. 12 (December 2012): 4336–39. https://doi.org/10.1172/JCI67055.
       Full Text  Link to Item
    • Mangos, Steve, Ansel P. Amaral, Christian Faul, Harald Jüppner, Jochen Reiser, and Myles Wolf. “Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio.” Nephrol Dial Transplant 27, no. 12 (December 2012): 4314–22. https://doi.org/10.1093/ndt/gfs335.
       Full Text  Link to Item
    • Levin, Gregory P., Cassianne Robinson-Cohen, Ian H. de Boer, Denise K. Houston, Kurt Lohman, Yongmei Liu, Stephen B. Kritchevsky, et al. “Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes.” Jama 308, no. 18 (November 14, 2012): 1898–1905. https://doi.org/10.1001/jama.2012.17304.
       Full Text  Link to Item
    • Isakova, Tamara, and Myles Wolf. “Partial answers from partial Klotho deficiency.” J Am Soc Nephrol 23, no. 10 (October 2012): 1599–1601. https://doi.org/10.1681/ASN.2012080848.
       Full Text  Link to Item
    • Wolf, Myles. “Update on fibroblast growth factor 23 in chronic kidney disease.” Kidney Int 82, no. 7 (October 2012): 737–47. https://doi.org/10.1038/ki.2012.176.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Ronit Katz, Carmen A. Peralta, Ian H. de Boer, David Siscovick, Myles Wolf, Ana Diez Roux, Bryan Kestenbaum, Jennifer A. Nettleton, and Joachim H. Ix. “Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA).” J Ren Nutr 22, no. 5 (September 2012): 480–89. https://doi.org/10.1053/j.jrn.2011.08.008.
       Full Text  Link to Item
    • deFilippi, Christopher, Stephen L. Seliger, Walter Kelley, Show-Hong Duh, Michael Hise, Robert H. Christenson, Myles Wolf, Hanna Gaggin, and James Januzzi. “Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome.” Clin Chem 58, no. 9 (September 2012): 1342–51. https://doi.org/10.1373/clinchem.2012.185322.
       Full Text  Link to Item
    • Block, Geoffrey A., David C. Wheeler, Martha S. Persky, Bryan Kestenbaum, Markus Ketteler, David M. Spiegel, Matthew A. Allison, et al. “Effects of phosphate binders in moderate CKD.” J Am Soc Nephrol 23, no. 8 (August 2012): 1407–15. https://doi.org/10.1681/ASN.2012030223.
       Full Text  Link to Item
    • Kanbay, Mehmet, Myles Wolf, Yusuf Selcoki, Yalcin Solak, Mustafa Ikizek, Sema Uysal, Liviu Segall, et al. “Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.” Int Urol Nephrol 44, no. 4 (August 2012): 1169–75. https://doi.org/10.1007/s11255-011-0076-x.
       Full Text  Link to Item
    • Ketteler, Markus, Kevin J. Martin, Myles Wolf, Michael Amdahl, Mario Cozzolino, David Goldsmith, Amit Sharma, Steven Marx, and Samina Khan. “Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study.” Nephrol Dial Transplant 27, no. 8 (August 2012): 3270–78. https://doi.org/10.1093/ndt/gfs018.
       Full Text  Link to Item
    • Leaf, David E., Myles Wolf, Sushrut S. Waikar, Herbert Chase, Marta Christov, Serge Cremers, and Leonard Stern. “FGF-23 levels in patients with AKI and risk of adverse outcomes.” Clin J Am Soc Nephrol 7, no. 8 (August 2012): 1217–23. https://doi.org/10.2215/CJN.00550112.
       Full Text  Link to Item
    • Bushinsky, David A., and Myles S. Wolf. “Mineral metabolism: confusion to clarity.” Curr Opin Nephrol Hypertens 21, no. 4 (July 2012): 353–54. https://doi.org/10.1097/MNH.0b013e3283546fec.
       Full Text  Link to Item
    • Munoz Mendoza, Jair, Tamara Isakova, Ana C. Ricardo, Huiliang Xie, Sankar D. Navaneethan, Amanda H. Anderson, Lydia A. Bazzano, et al. “Fibroblast growth factor 23 and Inflammation in CKD.” Clin J Am Soc Nephrol 7, no. 7 (July 2012): 1155–62. https://doi.org/10.2215/CJN.13281211.
       Full Text  Link to Item
    • Nielsen, Stine E., Henrik Reinhard, Dietmar Zdunek, Georg Hess, Orlando M. Gutiérrez, Myles Wolf, Hans-Henrik Parving, Peter K. Jacobsen, and Peter Rossing. “Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients.” Diabetes Res Clin Pract 97, no. 1 (July 2012): 71–76. https://doi.org/10.1016/j.diabres.2012.02.007.
       Full Text  Link to Item
    • Scialla, Julia J., Lawrence J. Appel, Myles Wolf, Wei Yang, Xiaoming Zhang, Stephen M. Sozio, Edgar R. Miller, et al. “Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study.” J Ren Nutr 22, no. 4 (July 2012): 379-388.e1. https://doi.org/10.1053/j.jrn.2012.01.026.
       Full Text  Link to Item
    • Isakova, Tamara, Huiliang Xie, Allison Barchi-Chung, Kelsey Smith, Nicole Sowden, Michael Epstein, Gina Collerone, Leigh Keating, Harald Jüppner, and Myles Wolf. “Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol.” Clin J Am Soc Nephrol 7, no. 5 (May 2012): 820–28. https://doi.org/10.2215/CJN.11721111.
       Full Text  Link to Item
    • Wahl, Patricia, Huiliang Xie, Julia Scialla, Cheryl A. M. Anderson, Keith Bellovich, Carolyn Brecklin, Jing Chen, et al. “Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease.” Diabetes Care 35, no. 5 (May 2012): 994–1001. https://doi.org/10.2337/dc11-2235.
       Full Text  Open Access Copy  Link to Item
    • Cortazar, F., M. Z. Molnar, T. Isakova, M. E. Czira, C. P. Kovesdy, D. Roth, I. Mucsi, and M. Wolf. “Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.” Am J Transplant 12, no. 2 (February 2012): 379–87. https://doi.org/10.1111/j.1600-6143.2011.03826.x.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Kelsey T. Smith, Allison Barchi-Chung, Neha M. Patel, Tamara Isakova, and Myles Wolf. “(1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.” Clin J Am Soc Nephrol 7, no. 1 (January 2012): 139–45. https://doi.org/10.2215/CJN.06240611.
       Full Text  Link to Item
    • Wahl, Patricia, and Myles Wolf. “FGF23 in chronic kidney disease.” Adv Exp Med Biol 728 (2012): 107–25. https://doi.org/10.1007/978-1-4614-0887-1_8.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Myles Wolf, and Eric N. Taylor. “Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.” Clin J Am Soc Nephrol 6, no. 12 (December 2011): 2871–78. https://doi.org/10.2215/CJN.02740311.
       Full Text  Link to Item
    • Scialla, Julia J., Mary B. Leonard, Raymond R. Townsend, Lawrence Appel, Myles Wolf, Matt J. Budoff, Jing Chen, et al. “Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease.” Clin J Am Soc Nephrol 6, no. 11 (November 2011): 2612–19. https://doi.org/10.2215/CJN.03910411.
       Full Text  Link to Item
    • Faul, Christian, Ansel P. Amaral, Behzad Oskouei, Ming-Chang Hu, Alexis Sloan, Tamara Isakova, Orlando M. Gutiérrez, et al. “FGF23 induces left ventricular hypertrophy.” J Clin Invest 121, no. 11 (November 2011): 4393–4408. https://doi.org/10.1172/JCI46122.
       Full Text  Link to Item
    • Isakova, Tamara, Huiliang Xie, Allison Barchi-Chung, Gabriela Vargas, Nicole Sowden, Jessica Houston, Patricia Wahl, et al. “Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.” Clin J Am Soc Nephrol 6, no. 11 (November 2011): 2688–95. https://doi.org/10.2215/CJN.04290511.
       Full Text  Link to Item
    • Block, Geoffrey A., and Myles Wolf. “Phosphate REINs in the renoprotective benefit of ACE inhibition.” J Am Soc Nephrol 22, no. 10 (October 2011): 1777–79. https://doi.org/10.1681/ASN.2011080833.
       Full Text  Link to Item
    • Carvalho, C., T. Isakova, G. Collerone, G. Olbina, M. Wolf, M. Westerman, and O. M. Gutiérrez. “Hepcidin and disordered mineral metabolism in chronic kidney disease.” Clin Nephrol 76, no. 2 (August 2011): 90–98. https://doi.org/10.5414/cn107018.
       Full Text  Link to Item
    • Isakova, Tamara, Orlando M. Gutiérrez, Neha M. Patel, Dennis L. Andress, Myles Wolf, and Adeera Levin. “Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions.” J Ren Nutr 21, no. 4 (July 2011): 295–302. https://doi.org/10.1053/j.jrn.2010.07.002.
       Full Text  Link to Item
    • Wolf, Myles, and David A. Bushinsky. “The beehive and the merry-go-round in mineral metabolism.” Curr Opin Nephrol Hypertens 20, no. 4 (July 2011): 329–30. https://doi.org/10.1097/MNH.0b013e328347c0b4.
       Full Text  Link to Item
    • Isakova, Tamara, Huiliang Xie, Wei Yang, Dawei Xie, Amanda Hyre Anderson, Julia Scialla, Patricia Wahl, et al. “Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.” Jama 305, no. 23 (June 15, 2011): 2432–39. https://doi.org/10.1001/jama.2011.826.
       Full Text  Link to Item
    • Wu-Wong, J Ruth, Yung-Wu Chen, Masaki Nakane, and Myles Wolf. “Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes.” Cardiovasc Drugs Ther 25, no. 3 (June 2011): 215–22. https://doi.org/10.1007/s10557-011-6287-7.
       Full Text  Link to Item
    • Isakova, Tamara, Patricia Wahl, Gabriela S. Vargas, Orlando M. Gutiérrez, Julia Scialla, Huiliang Xie, Dina Appleby, et al. “Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.” Kidney Int 79, no. 12 (June 2011): 1370–78. https://doi.org/10.1038/ki.2011.47.
       Full Text  Link to Item
    • Isakova, T., and M. Wolf. “Reply.” Nephrology Dialysis Transplantation 26, no. 5 (May 1, 2011): 1750. https://doi.org/10.1093/ndt/gfr042.
       Full Text
    • Wolf, Myles, Miklos Z. Molnar, Ansel P. Amaral, Maria E. Czira, Anna Rudas, Akos Ujszaszi, Istvan Kiss, et al. “Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.” J Am Soc Nephrol 22, no. 5 (May 2011): 956–66. https://doi.org/10.1681/ASN.2010080894.
       Full Text  Link to Item
    • Kovesdy, Csaba P., Istvan Mucsi, Maria E. Czira, Anna Rudas, Akos Ujszaszi, Laszlo Rosivall, S Joseph Kim, Myles Wolf, and Miklos Z. Molnar. “Association of serum phosphorus level with anemia in kidney transplant recipients.” Transplantation 91, no. 8 (April 27, 2011): 875–82. https://doi.org/10.1097/TP.0b013e3182111edf.
       Full Text  Link to Item
    • Isakova, Tamara, Cheryl A. M. Anderson, Mary B. Leonard, Dawei Xie, Orlando M. Gutiérrez, Leigh K. Rosen, Jacquie Theurer, et al. “Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort.” Nephrol Dial Transplant 26, no. 4 (April 2011): 1258–65. https://doi.org/10.1093/ndt/gfr026.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Tamara Isakova, Gwen Enfield, and Myles Wolf. “Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.” J Ren Nutr 21, no. 2 (March 2011): 140–48. https://doi.org/10.1053/j.jrn.2010.03.001.
       Full Text  Link to Item
    • Isakova, Tamara, Orlando M. Gutiérrez, Kelsey Smith, Michael Epstein, Leigh K. Keating, Harald Jüppner, and Myles Wolf. “Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease.” Nephrol Dial Transplant 26, no. 2 (February 2011): 584–91. https://doi.org/10.1093/ndt/gfq419.
       Full Text  Link to Item
    • Seeherunvong, Wacharee, and Myles Wolf. “Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation.” Pediatr Transplant 15, no. 1 (February 2011): 37–46. https://doi.org/10.1111/j.1399-3046.2010.01405.x.
       Full Text  Link to Item
    • Wang, T. J., F. Zhang, J. B. Richards, B. Kestenbaum, J. B. Van Meurs, D. Berry, D. P. Kiel, et al. “Common genetic determinants of vitamin D insufficiency: A genome-wide association study.” Obstetrical and Gynecological Survey 66, no. 2 (2011): 91–93. https://doi.org/10.1097/OGX.0b013e318216b03d.
       Full Text  Link to Item
    • Wolf, Myles. “Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone?” Semin Dial 24, no. 4 (2011): 428–30. https://doi.org/10.1111/j.1525-139X.2011.00914.x.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Tamara Isakova, Kelsey Smith, Michael Epstein, Neha Patel, and Myles Wolf. “Racial differences in postprandial mineral ion handling in health and in chronic kidney disease.” Nephrol Dial Transplant 25, no. 12 (December 2010): 3970–77. https://doi.org/10.1093/ndt/gfq316.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Cheryl Anderson, Tamara Isakova, Julia Scialla, Lavinia Negrea, Amanda Hyre Anderson, Keith Bellovich, et al. “Low socioeconomic status associates with higher serum phosphate irrespective of race.” J Am Soc Nephrol 21, no. 11 (November 2010): 1953–60. https://doi.org/10.1681/ASN.2010020221.
       Full Text  Link to Item
    • Isakova, Tamara, and Myles S. Wolf. “FGF23 or PTH: which comes first in CKD ?” Kidney Int 78, no. 10 (November 2010): 947–49. https://doi.org/10.1038/ki.2010.281.
       Full Text  Link to Item
    • Jüppner, Harald, Myles Wolf, and Isidro B. Salusky. “FGF-23: More than a regulator of renal phosphate handling?” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 25, no. 10 (October 2010): 2091–97. https://doi.org/10.1002/jbmr.170.
       Full Text
    • Wolf, Myles. “FGF23: fashion or physiology?” Clin J Am Soc Nephrol 5, no. 10 (October 2010): 1727–29. https://doi.org/10.2215/CJN.07410810.
       Full Text  Link to Item
    • Wolf, Myles. “Forging forward with 10 burning questions on FGF23 in kidney disease.” J Am Soc Nephrol 21, no. 9 (September 2010): 1427–35. https://doi.org/10.1681/ASN.2009121293.
       Full Text  Link to Item
    • Warsch, J. R. L., M. Wolf, and C. B. Wright. “Chronic kidney disease in patients with cognitive impairment: A marker of microvascular damage or an independent risk factor?” Aging Health 6, no. 4 (August 1, 2010): 423–27. https://doi.org/10.2217/ahe.10.47.
       Full Text
    • Wang, Thomas J., Feng Zhang, J Brent Richards, Bryan Kestenbaum, Joyce B. van Meurs, Diane Berry, Douglas P. Kiel, et al. “Common genetic determinants of vitamin D insufficiency: a genome-wide association study.” Lancet 376, no. 9736 (July 17, 2010): 180–88. https://doi.org/10.1016/S0140-6736(10)60588-0.
       Full Text  Link to Item
    • Bhan, Ishir, Anil Dubey, and Myles Wolf. “Diagnosis and management of mineral metabolism in CKD.” J Gen Intern Med 25, no. 7 (July 2010): 710–16. https://doi.org/10.1007/s11606-010-1316-y.
       Full Text  Link to Item
    • Szczech, Lynda A., David B. Bregman, Robert A. Harrington, David Morris, Angelia Butcher, Todd A. Koch, Lawrence T. Goodnough, Myles Wolf, and Jane E. Onken. “Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.” Nephrol Dial Transplant 25, no. 7 (July 2010): 2368–75. https://doi.org/10.1093/ndt/gfq218.
       Full Text  Link to Item
    • Zisman, Anna L., and Myles Wolf. “Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease.” Curr Opin Nephrol Hypertens 19, no. 4 (July 2010): 335–42. https://doi.org/10.1097/mnh.0b013e328338f536.
       Full Text  Link to Item
    • Patel, Neha M., Orlando M. Gutiérrez, Dennis L. Andress, Daniel W. Coyne, Adeera Levin, and Myles Wolf. “Vitamin D deficiency and anemia in early chronic kidney disease.” Kidney Int 77, no. 8 (April 2010): 715–20. https://doi.org/10.1038/ki.2009.551.
       Full Text  Link to Item
    • Leaf, David E., Myles Wolf, and Leonard Stern. “Elevated FGF-23 in a patient with rhabdomyolysis-induced acute kidney injury.” Nephrol Dial Transplant 25, no. 4 (April 2010): 1335–37. https://doi.org/10.1093/ndt/gfp682.
       Full Text  Link to Item
    • Isakova, T., O. M. Gutiérrez, and M. Wolf. “Response to Targeting hyperphosphatemia: Truth or dare.” Kidney International 77, no. 3 (January 1, 2010): 257. https://doi.org/10.1038/ki.2009.448.
       Full Text
    • Isakova, T., O. M. Gutiérrez, and M. Wolf. “The authors reply.” Kidney International 77, no. 8 (January 1, 2010): 743–44. https://doi.org/10.1038/ki.2009.535.
       Full Text
    • Isakova, T., O. M. Gutiérrez, and M. Wolf. “The authors reply.” Kidney International 77, no. 10 (January 1, 2010): 930. https://doi.org/10.1038/ki.2010.53.
       Full Text
    • Shimada, T., I. Urakawa, T. Isakova, Y. Yamazaki, M. Epstein, K. Wesseling-Perry, M. Wolf, I. B. Salusky, and H. Jüppner. “Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.” Journal of Clinical Endocrinology and Metabolism 95, no. 2 (January 1, 2010): 578–85. https://doi.org/10.1210/jc.2009-1603.
       Full Text
    • Cheng, Susan, Joseph M. Massaro, Caroline S. Fox, Martin G. Larson, Michelle J. Keyes, Elizabeth L. McCabe, Sander J. Robins, et al. “Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.” Diabetes 59, no. 1 (January 2010): 242–48. https://doi.org/10.2337/db09-1011.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., and Myles Wolf. “Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies.” Semin Dial 23, no. 4 (2010): 401–6. https://doi.org/10.1111/j.1525-139X.2010.00750.x.
       Full Text  Link to Item
    • Wolf, Myles. “Second chances in mineral metabolism.” Clin J Am Soc Nephrol 5, no. 1 (January 2010): 1–3. https://doi.org/10.2215/CJN.08131109.
       Full Text  Link to Item
    • Mehrotra, Rajnish, Dulcie A. Kermah, Isidro B. Salusky, Myles S. Wolf, Ravi I. Thadhani, Yi-Wen Chiu, David Martins, Sharon G. Adler, and Keith C. Norris. “Chronic kidney disease, hypovitaminosis D, and mortality in the United States.” Kidney Int 76, no. 9 (November 2009): 977–83. https://doi.org/10.1038/ki.2009.288.
       Full Text  Link to Item
    • Friedman, David J., Maryam Afkarian, Hector Tamez, Ishir Bhan, Tamara Isakova, Myles Wolf, Elizabeth Ankers, et al. “Klotho variants and chronic hemodialysis mortality.” Journal of Bone and Mineral Research : The Official Journal of the American Society for Bone and Mineral Research 24, no. 11 (November 2009): 1847–55. https://doi.org/10.1359/jbmr.090516.
       Full Text
    • Wolf, Myles. “Fibroblast growth factor 23 and the future of phosphorus management.” Curr Opin Nephrol Hypertens 18, no. 6 (November 2009): 463–68. https://doi.org/10.1097/MNH.0b013e328331a8c8.
       Full Text  Link to Item
    • Isakova, Tamara, Orlando M. Gutiérrez, and Myles Wolf. “A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease.” Kidney Int 76, no. 7 (October 2009): 705–16. https://doi.org/10.1038/ki.2009.246.
       Full Text  Link to Item
    • Oxnard, Geoffrey R., Tanya Milosh Zinkus, Hasan Bazari, and Myles Wolf. “Integrating research training into residency: tools of human investigation.” Acad Med 84, no. 9 (September 2009): 1295–1300. https://doi.org/10.1097/ACM.0b013e3181b18861.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., James L. Januzzi, Tamara Isakova, Karen Laliberte, Kelsey Smith, Gina Collerone, Ammar Sarwar, et al. “Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.” Circulation 119, no. 19 (May 19, 2009): 2545–52. https://doi.org/10.1161/CIRCULATIONAHA.108.844506.
       Full Text  Link to Item
    • Lee, Po-Shun, Kartik Sampath, S Ananth Karumanchi, Hector Tamez, Ishir Bhan, Tamara Isakova, Orlando M. Gutierrez, et al. “Plasma gelsolin and circulating actin correlate with hemodialysis mortality.” J Am Soc Nephrol 20, no. 5 (May 2009): 1140–48. https://doi.org/10.1681/ASN.2008091008.
       Full Text  Link to Item
    • Isakova, Tamara, Orlando M. Gutiérrez, Yuchiao Chang, Anand Shah, Hector Tamez, Kelsey Smith, Ravi Thadhani, and Myles Wolf. “Phosphorus binders and survival on hemodialysis.” J Am Soc Nephrol 20, no. 2 (February 2009): 388–96. https://doi.org/10.1681/ASN.2008060609.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Michael Mannstadt, Tamara Isakova, Jose Alejandro Rauh-Hain, Hector Tamez, Anand Shah, Kelsey Smith, et al. “Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.” N Engl J Med 359, no. 6 (August 7, 2008): 584–92. https://doi.org/10.1056/NEJMoa0706130.
       Full Text  Link to Item
    • Wolf, Myles. “Active vitamin D and survival.” J Am Soc Nephrol 19, no. 8 (August 2008): 1442–43. https://doi.org/10.1681/ASN.2008060595.
       Full Text  Link to Item
    • Gutiérrez, Orlando M., Hector Tamez, Ishir Bhan, James Zazra, Marcello Tonelli, Myles Wolf, James L. Januzzi, Yuchiao Chang, and Ravi Thadhani. “N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements.” Clin Chem 54, no. 8 (August 2008): 1339–48. https://doi.org/10.1373/clinchem.2007.101691.
       Full Text  Link to Item
    • Nigwekar, Sagar U., Myles Wolf, Richard H. Sterns, and John K. Hix. “Calciphylaxis from nonuremic causes: a systematic review.” Clin J Am Soc Nephrol 3, no. 4 (July 2008): 1139–43. https://doi.org/10.2215/CJN.00530108.
       Full Text  Link to Item
    • Wolf, Myles, Joseph Betancourt, Yuchiao Chang, Anand Shah, Ming Teng, Hector Tamez, Orlando Gutierrez, et al. “Impact of activated vitamin D and race on survival among hemodialysis patients.” J Am Soc Nephrol 19, no. 7 (July 2008): 1379–88. https://doi.org/10.1681/ASN.2007091002.
       Full Text  Link to Item
    • Gutiérrez, O. M., T. Isakova, D. L. Andress, A. Levin, and M. Wolf. “Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease.” Kidney Int 73, no. 8 (April 2008): 956–62. https://doi.org/10.1038/ki.2008.4.
       Full Text  Link to Item
    • Isakova, Tamara, Orlando Gutierrez, Anand Shah, Lorraine Castaldo, Julie Holmes, Hang Lee, and Myles Wolf. “Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD.” J Am Soc Nephrol 19, no. 3 (March 2008): 615–23. https://doi.org/10.1681/ASN.2007060673.
       Full Text  Link to Item
    • Patel, T. V., L. Cornell, and M. Wolf. “Renal metastases.” Kidney Int 73, no. 3 (February 2008): 370. https://doi.org/10.1038/sj.ki.5002594.
       Full Text  Link to Item
    • Wang, Thomas J., Michael J. Pencina, Sarah L. Booth, Paul F. Jacques, Erik Ingelsson, Katherine Lanier, Emelia J. Benjamin, Ralph B. D’Agostino, Myles Wolf, and Ramachandran S. Vasan. “Vitamin D deficiency and risk of cardiovascular disease.” Circulation 117, no. 4 (January 29, 2008): 503–11. https://doi.org/10.1161/CIRCULATIONAHA.107.706127.
       Full Text  Link to Item
    • Wolf, M. “Improving survival of dialysis patients with active vitamin D.” Nieren  Und Hochdruckkrankheiten 37, no. 5 (January 1, 2008): 224–28. https://doi.org/10.5414/nhp37224.
       Full Text
    • Wolf, M., and R. Thadhani. “Response to 'Vitamin D levels and early mortality among incident hemodialysis patients'.” Kidney International 74, no. 3 (January 1, 2008): 389. https://doi.org/10.1038/ki.2008.172.
       Full Text
    • Wolf, M., A. Shah, O. Gutierrez, E. Ankers, M. Monroy, H. Tamez, D. Steele, et al. “Vitamin D levels and early mortality among incident hemodialysis patients.” Kidney Int 72, no. 8 (October 2007): 1004–13. https://doi.org/10.1038/sj.ki.5002451.
       Full Text  Link to Item
    • Chafetz, Ilana, Ido Kuhnreich, Marei Sammar, Yossi Tal, Yair Gibor, Hamutal Meiri, Howard Cuckle, and Myles Wolf. “First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.” Am J Obstet Gynecol 197, no. 1 (July 2007): 35.e1-35.e7. https://doi.org/10.1016/j.ajog.2007.02.025.
       Full Text  Link to Item
    • Martins, David, Myles Wolf, Deyu Pan, Ashraf Zadshir, Naureen Tareen, Ravi Thadhani, Arnold Felsenfeld, Barton Levine, Rajnish Mehrotra, and Keith Norris. “Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.” Arch Intern Med 167, no. 11 (June 11, 2007): 1159–65. https://doi.org/10.1001/archinte.167.11.1159.
       Full Text  Link to Item
    • Smirnakis, Karen V., Alicia Plati, Myles Wolf, Ravi Thadhani, and Jeffrey L. Ecker. “Predicting gestational diabetes: choosing the optimal early serum marker.” Am J Obstet Gynecol 196, no. 4 (April 2007): 410.e1-410.e6. https://doi.org/10.1016/j.ajog.2006.12.011.
       Full Text  Link to Item
    • Wolf, Myles, and Ravi Thadhani. “Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward.” J Steroid Biochem Mol Biol 103, no. 3–5 (March 2007): 487–90. https://doi.org/10.1016/j.jsbmb.2006.11.009.
       Full Text  Link to Item
    • Thadhani, Ravi, and Myles Wolf. “Vitamin D in patients with kidney disease: cautiously optimistic.” Adv Chronic Kidney Dis 14, no. 1 (January 2007): 22–26. https://doi.org/10.1053/j.ackd.2006.10.009.
       Full Text  Link to Item
    • Bhan, I., A. Shah, J. Holmes, T. Isakova, O. Gutierrez, S. M. Burnett, H. Jüppner, and M. Wolf. “Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?” Kidney Int 70, no. 8 (October 2006): 1486–94. https://doi.org/10.1038/sj.ki.5001788.
       Full Text  Link to Item
    • Polu, Krishna R., and Myles Wolf. “Clinical problem-solving. Needle in a haystack.” N Engl J Med 354, no. 1 (January 5, 2006): 68–73. https://doi.org/10.1056/NEJMcps051939.
       Full Text  Link to Item
    • Smirnakis, Karen V., Lisa Chasan-Taber, Myles Wolf, Glenn Markenson, Jeffrey L. Ecker, and Ravi Thadhani. “Postpartum diabetes screening in women with a history of gestational diabetes.” Obstet Gynecol 106, no. 6 (December 2005): 1297–1303. https://doi.org/10.1097/01.AOG.0000189081.46925.90.
       Full Text  Link to Item
    • Wolf, Myles, Henry Rose, and R Neal Smith. “Case records of the Massachusetts General Hospital. Case 28-2005. A 42-year-old man with weight loss, weakness, and a rash.” N Engl J Med 353, no. 11 (September 15, 2005): 1148–57. https://doi.org/10.1056/NEJMcpc059022.
       Full Text  Link to Item
    • Rajakumar, A., H. M. Michael, P. A. Rajakumar, E. Shibata, C. A. Hubel, S Ananth Karumanchi, R. Thadhani, M. Wolf, G. Harger, and N. Markovic. “Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.” Placenta 26, no. 7 (August 2005): 563–73. https://doi.org/10.1016/j.placenta.2004.09.001.
       Full Text  Link to Item
    • Gutierrez, Orlando, Tamara Isakova, Eugene Rhee, Anand Shah, Julie Holmes, Gina Collerone, Harald Jüppner, and Myles Wolf. “Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.” J Am Soc Nephrol 16, no. 7 (July 2005): 2205–15. https://doi.org/10.1681/ASN.2005010052.
       Full Text  Link to Item
    • Wolf, Myles, Anand Shah, Chun Lam, Abelardo Martinez, Karen V. Smirnakis, Franklin H. Epstein, Robert N. Taylor, Jeffrey L. Ecker, S Ananth Karumanchi, and Ravi Thadhani. “Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.” Am J Obstet Gynecol 193, no. 1 (July 2005): 16–22. https://doi.org/10.1016/j.ajog.2005.03.016.
       Full Text  Link to Item
    • Smirnakis, Karen V., Abelardo Martinez, Karen Hsu Blatman, Myles Wolf, Jeffrey L. Ecker, and Ravi Thadhani. “Early pregnancy insulin resistance and subsequent gestational diabetes mellitus.” Diabetes Care 28, no. 5 (May 2005): 1207–8. https://doi.org/10.2337/diacare.28.5.1207.
       Full Text  Link to Item
    • Teng, Ming, Myles Wolf, M Norma Ofsthun, J Michael Lazarus, Miguel A. Hernán, Carlos A. Camargo, and Ravi Thadhani. “Activated injectable vitamin D and hemodialysis survival: a historical cohort study.” J Am Soc Nephrol 16, no. 4 (April 2005): 1115–25. https://doi.org/10.1681/ASN.2004070573.
       Full Text  Link to Item
    • Wolf, Myles, and Ravi Thadhani. “Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease.” Semin Dial 18, no. 4 (2005): 302–6. https://doi.org/10.1111/j.1525-139X.2005.18406.x.
       Full Text  Link to Item
    • Wolf, Myles, Carl A. Hubel, Chun Lam, Marybeth Sampson, Jeffrey L. Ecker, Roberta B. Ness, Augustine Rajakumar, et al. “Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.” J Clin Endocrinol Metab 89, no. 12 (December 2004): 6239–43. https://doi.org/10.1210/jc.2004-0548.
       Full Text  Link to Item
    • Wieland, A., A. Mehta, A. Greenfield, and M. Wolf. “Temporary suprarenal inferior vena cava filter for renal biopsy in a patient with renal vein thrombosis.” Clin Nephrol 62, no. 3 (September 2004): 239–41. https://doi.org/10.5414/cnp62239.
       Full Text  Link to Item
    • Thadhani, Ravi, Jeffrey L. Ecker, Walter P. Mutter, Myles Wolf, Karen V. Smirnakis, Vikas P. Sukhatme, Richard J. Levine, and S Ananth Karumanchi. “Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.” Hypertension 43, no. 5 (May 2004): 988–92. https://doi.org/10.1161/01.HYP.0000124460.67539.1d.
       Full Text  Link to Item
    • Wolf, Myles, Anand Shah, Ricardo Jimenez-Kimble, Jenny Sauk, Jeffrey L. Ecker, and Ravi Thadhani. “Differential risk of hypertensive disorders of pregnancy among Hispanic women.” J Am Soc Nephrol 15, no. 5 (May 2004): 1330–38. https://doi.org/10.1097/01.asn.0000125615.35046.59.
       Full Text  Link to Item
    • Thadhani, Ravi, Walter P. Mutter, Myles Wolf, Richard J. Levine, Robert N. Taylor, Vikas P. Sukhatme, Jeffrey Ecker, and S Ananth Karumanchi. “First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.” J Clin Endocrinol Metab 89, no. 2 (February 2004): 770–75. https://doi.org/10.1210/jc.2003-031244.
       Full Text  Link to Item
    • Wolf, Myles, Jenny Sauk, Anand Shah, Karen Vossen Smirnakis, Ricardo Jimenez-Kimble, Jeffrey L. Ecker, and Ravi Thadhani. “Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus.” Diabetes Care 27, no. 1 (January 2004): 21–27. https://doi.org/10.2337/diacare.27.1.21.
       Full Text  Link to Item
    • Colussi, Giacomo. “Paricalcitol, calcitriol, and survival of patients undergoing hemodialysis.” N Engl J Med 349, no. 20 (November 13, 2003): 1971–72. https://doi.org/10.1056/NEJM200311133492018.
       Full Text  Link to Item
    • Teng, Ming, Myles Wolf, Edmund Lowrie, Norma Ofsthun, J Michael Lazarus, and Ravi Thadhani. “Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.” N Engl J Med 349, no. 5 (July 31, 2003): 446–56. https://doi.org/10.1056/NEJMoa022536.
       Full Text  Link to Item
    • Thadhani, Ravi, Myles Wolf, Karen Hsu-Blatman, Laura Sandler, David Nathan, and Jeffrey L. Ecker. “First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus.” Am J Obstet Gynecol 189, no. 1 (July 2003): 171–76. https://doi.org/10.1067/mob.2003.343.
       Full Text  Link to Item
    • Wolf, Myles, Laura Sandler, Karen Hsu, Karen Vossen-Smirnakis, Jeffrey L. Ecker, and Ravi Thadhani. “First-trimester C-reactive protein and subsequent gestational diabetes.” Diabetes Care 26, no. 3 (March 2003): 819–24. https://doi.org/10.2337/diacare.26.3.819.
       Full Text  Link to Item
    • Wolf, Myles, Laura Sandler, Ricardo Jimenez-Kimble, Anand Shah, Jeffrey L. Ecker, and Ravi Thadhani. “Insulin resistance but not inflammation is associated with gestational hypertension.” Hypertension 40, no. 6 (December 2002): 886–91. https://doi.org/10.1161/01.hyp.0000042085.65467.9f.
       Full Text  Link to Item
    • Wolf, Myles. “Clinical research career development: the individual perspective.” Acad Med 77, no. 11 (November 2002): 1084–88. https://doi.org/10.1097/00001888-200211000-00004.
       Full Text  Link to Item
    • Wolf, Myles, Laura Sandler, Kristine Muñoz, Karen Hsu, Jeffrey L. Ecker, and Ravi Thadhani. “First trimester insulin resistance and subsequent preeclampsia: a prospective study.” J Clin Endocrinol Metab 87, no. 4 (April 2002): 1563–68. https://doi.org/10.1210/jcem.87.4.8405.
       Full Text  Link to Item
    • Thadhani, Ravi, Myles Wolf, Michael L. West, Marcello Tonelli, Robin Ruthazer, Gregory M. Pastores, and Gregorio T. Obrador. “Patients with Fabry disease on dialysis in the United States.” Kidney Int 61, no. 1 (January 2002): 249–55. https://doi.org/10.1046/j.1523-1755.2002.00097.x.
       Full Text  Link to Item
    • Wolf, M., E. Kettyle, L. Sandler, J. L. Ecker, J. Roberts, and R. Thadhani. “Obesity and preeclampsia: the potential role of inflammation.” Obstet Gynecol 98, no. 5 Pt 1 (November 2001): 757–62. https://doi.org/10.1016/s0029-7844(01)01551-4.
       Full Text  Link to Item
    • Wolf, M. “Case of the month misdiagnosis.” Am J Med 108, no. 3 (February 15, 2000): 263. https://doi.org/10.1016/s0002-9343(99)00403-9.
       Full Text  Link to Item

  • Book Sections

    • Houston, J., T. Isakova, and M. Wolf. “Phosphate Metabolism and Fibroblast Growth Factor 23 in Chronic Kidney Disease.” In Nutritional Management of Renal Disease, 285–308, 2013. https://doi.org/10.1016/B978-0-12-391934-2.00020-5.
       Full Text

  • Digital Publications

    • Lunyera, Joseph, Clemontina A. Davenport, Jane Pendergast, Solomon K. Musani, Nrupen A. Bhavsar, Mario Sims, Stanford Mwasongwe, et al. “Modifiers of Plasma 25-Hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study.,” June 1, 2019. https://doi.org/10.1210/jc.2018-01747.
       Full Text  Open Access Copy  Link to Item

  • Conference Papers

    • Babitt, Jodie L., Michele F. Eisenga, Volker H. Haase, Abhijit V. Kshirsagar, Adeera Levin, Francesco Locatelli, Jolanta Małyszko, et al. “Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference.” In Kidney Int, 99:1280–95, 2021. https://doi.org/10.1016/j.kint.2021.03.020.
       Full Text  Link to Item
    • Robinson-Cohen, Cassianne, Farzana Perwad, Myles S. Wolf, Ian H. De Boer, Bryan Kestenbaum, Loren Lipworth, Adriana Hung, and T Alp Ikizler. “Genetic Variants Associated with Circulating Parathyroid Hormone among Patients with Chronic Kidney Disease.” In Journal of Bone and Mineral Research, 33:230–230. WILEY, 2018.
       Link to Item
    • Neuburg, Samantha, Corey Dussold, Claire Gerber, Xueyan Wang, Connor Francis, Lixin Qi, Valentin David, Myles Wolf, and Aline Martin. “Genetic background influences cardiac phenotype in murine chronic kidney disease.” In Nephrol Dial Transplant, 33:1129–37, 2018. https://doi.org/10.1093/ndt/gfx332.
       Full Text  Link to Item
    • Wolf, Myles, Matthew R. Weir, Nelson Kopyt, Roslyn B. Mannon, Jon Von Visger, Hongjie Deng, Susan Yue, and Flavio Vincenti. “A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation.” In Transplantation, 100:184–93, 2016. https://doi.org/10.1097/TP.0000000000000823.
       Full Text  Link to Item
    • Hubel, Carl A., Gerd Wallukat, Myles Wolf, Florian Herse, Augustine Rajakumar, James M. Roberts, Nina Markovic, Ravi Thadhani, Friedrich C. Luft, and Ralf Dechend. “Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.” In Hypertension, 49:612–17, 2007. https://doi.org/10.1161/01.HYP.0000256565.20983.d4.
       Full Text  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.